Pulmonary embolism or thrombosis in ARDS COVID-19 patients: A French monocenter retrospective study

Contou D, Pajot O, Cally R, Logre E, Fraissé M, Mentec H, Plantefève G.

Utility of D-dimer as a Prognostic Factor in SARS CoV2 Infection: A Review

Kariyanna PT, Aurora L, Jayarangaiah A, Yadav V, Hossain NA, Akter N, Salifu MO, McFarlane IM.

Incidence of Venous Thromboembolism in Hospitalized Coronavirus Disease 2019 Patients: A Systematic Review and Meta-Analysis

Zhang C, Shen L, Le KJ, Pan MM, Kong LC, Gu ZC, Xu H, Zhang Z, Ge WH, Lin HW.

Is therapeutic anticoagulation improving renal outcomes in COVID-19?

Roomi S, Ullah W, Farooq S, Saeed R, Haq S, Ashfaq AA.

A Controllable Inflammatory Response and Temporary Abnormal Coagulation in Moderate Disease of COVID-19 in Wuhan, China

Liu Y, Zhang X, Qiao J, Gong R, You Q, Sun J, Liu W, Sun B.

Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity

Pasquarelli-do-Nascimento G, Braz-de-Melo HA, Faria SS, Santos IO, Kobinger GP, Magalh√£es KG.

Unpuzzling COVID-19 Prothrombotic State: Are Preexisting Thrombophilic Risk Profiles Responsible for Heterogenous Thrombotic Events?

Burlacu A, Genovesi S, Popa IV, Crisan-Dabija R.

The management of venous thromboembolism in hospitalized patients with COVID-19

Spyropoulos AC.

Prevalence of pulmonary embolism in patients with COVID-19 pneumonia and high D-dimer values: A prospective study

Alonso-Fernández A, Toledo-Pons N, Cosío BG, Millán A, Calvo N, Ramón L, de Mendoza SH, Morell-García D, Bauça-Rossello JM, Núñez B, Pons J, Palmer JA, Martín L, Peñaranda M, Pou JA, Sauleda J, Sala-Llinas E.

Prevalence of asymptomatic deep vein thrombosis in patients hospitalized with SARS-CoV-2 pneumonia: a cross-sectional study

Giorgi-Pierfranceschi M, Paoletti O, Pan A, De Gennaro F, Nardecchia AL, Morandini R, Dellanoce C, Lombi S, Tala M, Cancelli V, Zambelli S, Bosio G, Romanini L, Testa S.

Thrombosis and Thromboembolism Related to COVID-19: Increase the Level of Awareness, Lower the Threshold of Suspicion, and Keep Following the Guidelines

Konstantinides SV.

Anticoagulation use and Hemorrhagic Stroke in SARS-CoV-2 Patients Treated at a New York Healthcare System

Kvernland A, Kumar A, Yaghi S, Raz E, Frontera J, Lewis A, Czeisler B, Kahn DE, Zhou T, Ishida K, Torres J, Riina HA, Shapiro M, Nossek E, Nelson PK, Tanweer O, Gordon D, Jain R, Dehkharghani S, Henninger N, de Havenon A, Grory BM, Lord A, Melmed K.

Association between renin-angiotensin-aldosterone system inhibitor treatment, neutrophil-lymphocyte ratio, D-Dimer and clinical severity of COVID-19 in hospitalized patients: a multicenter, observational study

Gormez S, Ekicibasi E, Degirmencioglu A, Paudel A, Erdim R, Gumusel HK, Eroglu E, Tanboga IH, Dagdelen S, Sariguzel N, Kirisoglu CE, Pamukcu B.

Intraoperative coagulopathy during cesarean section as an unsuspected initial presentation of COVID-19: a case report

Kinsey KE, Ganz E, Khalil S, Brustman L.

Acute COVID-19 Induced Fulminant Systemic Vascular Thrombosis: A Novel Entity

Ali Z, Ullah W, Saeed R, Ashfaq A, Lashari B.

4 Cases of Aortic Thrombosis in Patients With COVID-19

Woehl B, Lawson B, Jambert L, Tousch J, Ghassani A, Hamade A.

Right Ventricular Clot in Transit in COVID-19: Implications for the Pulmonary Embolism Response Team

Sethi SS, Zilinyi R, Green P, Eisenberger A, Brodie D, Agerstrand C, Takeda K, Kirtane AJ, Parikh SA, Rosenzweig EB.

Difficulties of Managing Submassive and Massive Pulmonary Embolism in the Era of COVID-19

Marginean A, Masic D, Brailovsky Y, Fareed J, Darki A.

A Case Series of Stent Thrombosis During the COVID-19 Pandemic

Prieto-Lobato A, Ramos-Martínez R, Vallejo-Calcerrada N, Corbí-Pascual M, Córdoba-Soriano JG.

Pulmonary intravascular coagulopathy in COVID-19 pneumonia - Authors' reply

McGonagle D, O'Donnell JS, Sharif K, Emery P, Bridgewood C.

Pulmonary intravascular coagulopathy in COVID-19 pneumonia

C√°rdenas Suri H.

Pulmonary intravascular coagulopathy in COVID-19 pneumonia

Reines BP, Ninham BW.

Pulmonary intravascular coagulopathy in COVID-19 pneumonia

Brondani G, Apollonio L, Gremese E, Ferraccioli G.

Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia

McGonagle D, O'Donnell JS, Sharif K, Emery P, Bridgewood C.

Arterial thrombotic complications in COVID-19 patients

Levolger S, Bokkers RPH, Wille J, Kropman RHJ, de Vries JPM.

COVID-19 and thrombosis: Beyond a casual association

López Castro J.

Insidious development of pulmonary embolism in asymptomatic patients with COVID-19: Two rare case-reports

Alharthy A, Balhamar A, Faqihi F, Alshaya R, Noor A, Alaklobi F, Memish ZA, Karakitsos D.

How to manage thromboembolic risk in patient with SARS-CoV-2-related disease in the Emergency Department: A case report of cardiogenic shock due to massive pulmonary embolism

Colombo L, Macheda A, Gentile D, Panizzardi F, Pierini S, Codazzi C, Meloni L, Bianchi F, Santangelo G.

SARS-CoV2 induced pulmonary embolism and complications from anticoagulation

Turshudzhyan A.

[Arterial thrombotic complications in hospitalized patients with COVID-19]

Rey JR, Caro-Codón J, Poveda Pineda D, Merino JL, Iniesta ÁM, López-Sendón JL; investigadores CARD-COVID.

[COVID-19 quarantine and acute pulmonary embolism]

Vannini L, Llanos Gómez JM, Quijada-Fumero A, Fernández Pérez AB, Hernández Afonso JS.

[Pulmonary infarction secondary to pulmonary thromboembolism in COVID-19 diagnosed with dual-energy CT pulmonary angiography]

Marsico S, Espallargas Giménez I, Carbullanca Toledo SJ, Del Carpio Bellido LA, Maiques Llácer JM, Zuccarino F.

[Pulmonary embolism in COVID-19. When nothing is what it seems]

Ioan AM, Durante-López A, Martínez-Milla J, Pérez-Calvo C, Santos A.

Extensive Aortic Thrombosis in a Patient With COVID-19

Katchanov J, Kalisch J, Herzing W, Knorr F, Havla M, Klink T, Dommke C.

Variability in Institutional Guidance for COVID-19-Associated Coagulopathy in the United States

Patell R, Midha S, Kimani S, Martin R, Neparidze N, Jaglal M, Freed J, Key NS.

Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients

Li C, Jiang J, Wang F, Zhou N, Veronese G, Moslehi JJ, Ammirati E, Wang DW.

COVID-19: a probable role of the anticoagulant Protein S in managing COVID-19-associated coagulopathy

Chatterjee S, Sengupta T, Majumder S, Majumder R.

Incidence of venous and arterial thromboembolic complications in COVID-19: A systematic review and meta-analysis

Kunutsor SK, Laukkanen JA.

Right ventricular dilation: The additive effect of mechanical ventilation on pulmonary embolism in Covid-19 patients

Tsolaki V, Zakynthinos GE, Mantzarlis K.

Drive-Through Model for Anticoagulation Clinics During the COVID-19 Pandemic

Rezaei Bookani K, Minga I, Chander M, Hankewych K, Plassmeier M, Tafur A.

COVID-19 Presenting as Acute Bilateral Submassive Pulmonary Embolism in a Young Healthy Female

Fransawy Alkomos M, Aron P, Laxina I, Sanchez J, Agnelli M.

COVID-19 suspicion revealed to be fat embolism syndrome

Mazouz S, Aissaoui O, Fehdi MA, Nsiri A, AlHarrar R.

Hemoperfusion as a Supportive Treatment in a COVID-19 Patient with Late Pulmonary Thromboembolism: A Case Report

Moradi H, Abbasi S.

Pharmacotherapy for Prevention and Management of Thrombosis in COVID-19

Hashemi A, Madhavan MV, Bikdeli B.

COVID-19-Associated Carotid Atherothrombosis and Stroke

Esenwa C, Cheng NT, Lipsitz E, Hsu K, Zampolin R, Gersten A, Antoniello D, Soetanto A, Kirchoff K, Liberman A, Mabie P, Nisar T, Rahimian D, Brook A, Lee SK, Haranhalli N, Altschul D, Labovitz D.

Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19

Godoy LC, Goligher EC, Lawler PR, Slutsky AS, Zarychanski R.

Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis

Abdel-Maboud M, Menshawy A, Elgebaly A, Bahbah EI, El Ashal G, Negida A.

Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial

Houston BL, Lawler PR, Goligher EC, Farkouh ME, Bradbury C, Carrier M, Dzavik V, Fergusson DA, Fowler RA, Galanaud JP, Gross PL, McDonald EG, Husain M, Kahn SR, Kumar A, Marshall J, Murthy S, Slutsky AS, Turgeon AF, Berry SM, Rosenson RS, Escobedo J, Nicolau JC, Bond L, Kirwan BA, de Brouwer S, Zarychanski R.

COVID-19 and venous thromboembolism - prophylaxis and treatment

Kvåle R, Azrakhsh NA, Mohn KG, Aanerud M, Guttormsen AB, Reikvam H.

Impact of COVID-19 on monitoring of therapeutic unfractionated heparin

Adie SK, Farina N.

[Coagulopathy and thrombosis: similarities and differences among pathogenic coronaviruses]

P√°ramo JA.

Infection and thrombosis associated with COVID-19: Possible role of the ABO blood group

Zalba Marcos S, Antelo ML, Galbete A, Etayo M, Ongay E, García-Erce JA.

Pulmonary embolism in patients with COVID-19 and its treatment based on low-molecular-weight heparin

Hosseini A, Bahramnezhad F.

SARS-Cov-2 Infection and Pulmonary Thromboembolism - The Prothrombotic State in COVID-19

Passos HD, Alves MC, Baumworcel L, Vieira JPC, Garcez JDS, Sousa ACS.

Editorial Comment on "Multisystem assessment of the imaging manifestations of coagulopathy in hospitalized patients with COVID-19"

Dasyam AK.

High prevalence of early asymptomatic venous thromboembolism in anticoagulated COVID-19 patients hospitalized in general wards

Le Jeune S, Suhl J, Benainous R, Minvielle F, Purser C, Foudi F, Warzocha U, Dhote R.

Immunothrombosis in severe COVID-19

Nakazawa D, Ishizu A.

Heparin-induced thrombocytopenia and thrombosis in a patient with Covid-19

Huang CT, Hsu SY, Chang KW, Huang CG, Yang CT, Cheng MH.

Early detection of deep vein thrombosis in patients with coronavirus disease 2019: who to screen and who not to with Doppler ultrasound?

Ierardi AM, Coppola A, Fusco S, Stellato E, Aliberti S, Andrisani MC, Vespro V, Arrichiello A, Panigada M, Monzani V, Grasselli G, Venturini M, Rehani B, Peyvandi F, Pesenti A, Blasi F, Carrafiello G.

Anticoagulant treatment in COVID-19: a narrative review

Carfora V, Spiniello G, Ricciolino R, Di Mauro M, Migliaccio MG, Mottola FF, Verde N, Coppola N; Vanvitelli COVID-19 group.

Acro-ischemic lesions associated with extremely elevated D-Dimer in a child during the COVID-19 pandemic

García-Gil MF, Monte Serrano J, García García M, Pascual-Del-Riquelme JA, Ara-Martín M.

Thrombotic complications and anticoagulation in COVID-19 pneumonia: a New York City hospital experience

Hanif A, Khan S, Mantri N, Hanif S, Saleh M, Alla Y, Chinta S, Shrestha N, Ji W, Attwood K, Adrish M, Jain KR.

Venous Thromboembolism in Hospitalized COVID-19 Patients: A Systematic Review

Birkeland K, Zimmer R, Kimchi A, Kedan I.

Anti Xa activity after high dose LMWH thrombosis prophylaxis in covid 19 patients at the intensive care unit

Vlot EA, Van den Dool EJ, Hackeng CM, Sohne M, Noordzij PG, Van Dongen EPA.

Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC)

Pawlowski C, Wagner T, Puranik A, Murugadoss K, Loscalzo L, Venkatakrishnan AJ, Pruthi RK, Houghton DE, O'Horo JC, Morice WG, Williams AW, Gores GJ, Halamka J, Badley Md AD, Barnathan ES, Makimura H, Khan N, Soundararajan V.

Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis

Kessler C, Stricker H, Demundo D, Elzi L, Monotti R, Bianchi G, Llamas M, Spinedi L, Rossi D, Chiesa AF, Pagnamenta A, Conti M, Casso G, Stoira E, Valenti E, Colucci G, Stussi G, Gerber B, Previsdomini M.

Management of Thrombotic Complications in COVID-19: An Update

Hajra A, Mathai SV, Ball S, Bandyopadhyay D, Veyseh M, Chakraborty S, Lavie CJ, Aronow WS.

Acute Limb Ischemia in COVID-19 Disease: A Mysterious Coagulopathy

Anwar S, Acharya S, Shabih S, Khabut A.

Acute Aortic Thrombosis Revealing a COVID-19 Infection

Coscas R, Coggia M.

Pulmonary Embolism in Patients Hospitalized With COVID-19 (From a New York Health System)

Xu H, Martin A, Singh A, Narasimhan M, Lau J, Weinberg M, Jauhar R, Rao G.

Severe arterial thromboembolism in patients with Covid-19

Lameijer JRC, van Houte J, van Berckel MMG, Canta LR, Yo LSF, Nijziel MR, Krietemeijer GM, Troquay SAM, Buise MP, Hendriks J.

A meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19

Lu YF, Pan LY, Zhang WW, Cheng F, Hu SS, Zhang X, Jiang HY.

D-dimer and right ventricular abnormalities as prognostic factors in critically ill COVID-19 patients

Gonzalez-Fernandez O, Ponz de Antonio I, Rosillo Rodriguez SO, Ruiz Cantador J, Figueira Iglesias JC, Lopez-Sendon Hentschel JL.

Baricitinib: Impact on COVID-19 coagulopathy?

Jorgensen SCJ, Burry L, Tse CLY, Dresser LD.

Response to Correspondence: Baricitinib - Impact on COVID-19 Coagulopathy? Jorgensen et. al

Titanji BK, Farley MM, Schinazi RF, Marconi VC.

COVID-19 Associated Coagulopathy and Thrombotic Complications

Mezalek ZT, Khibri H, Ammouri W, Bouaouad M, Haidour S, Harmouche H, Maamar M, Adnaoui M.

Safety of intermediate dose of low molecular weight heparin in COVID-19 patients

Mattioli M, Benfaremo D, Mancini M, Mucci L, Mainquà P, Polenta A, Baldini PM, Fulgenzi F, Dennetta D, Bedetta S, Gasperoni L, Caraffa A, Frausini G.

Liver abnormality may develop cerebral venous sinus thrombosis in COVID-19

Neshin SAS, Basirjafari S, Saberi A, Shahhosseini B, Zarei M.

Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance and their limitations

Hardy M, Douxfils J, Bareille M, Lessire S, Gouin-Thibault I, Fontana P, Lecompte T, Mullier F.

Successful management of COVID-19 and associated coagulopathy in a patient with durable left ventricular assist device

Hodges K, Mubashir M, Insler J, Estep J, Hsich E, Tong M, Insler S, Soltesz E.

In vivo demonstration of microvascular thrombosis in severe COVID-19

do Espírito Santo DA, Lemos ACB, Miranda CH.

Non-Bacterial Thrombotic Endocarditis: A Presentation of COVID-19

Balata D, Mellergård J, Ekqvist D, Baranowski J, Garcia IA, Volosyraki M, Broqvist M.

A Peculiar Case of Priapism: The Hypercoagulable State in Patients with Severe COVID-19 Infection

Lam G, McCarthy R, Haider R.

Infiltrative Shadows in COVID-19: Pneumonia or Pulmonary Embolism?

Nagai H, Yamamoto S, Saito M, Adachi E.

Coronavirus Disease 2019: Hematological Anomalies and Antithrombotic Therapy

Ornelas-Ricardo D, Jaloma-Cruz AR.

Antiphospholipid antibodies and thrombosis in severe COVID-19 pneumonia: A difficult relationship

Pavoni V, Gianesello L.

Portal vein thrombosis in a patient with COVID-19

Franco-Moreno A, Piniella-Ruiz E, Montoya-Adarraga J, Ballano-Franco C, Alvarez-Miguel F, Peinado-Martinez C, Landete-Hernandez E, Saez-Vaquero T, Ulla-Anes M, Torres-Macho J.

Venous thromboembolism and coronavirus disease 2019 in an ambulatory care setting - A report of 4 cases

Overstad S, Tjonnfjord E, Garabet L, Fronas S, Bergan J, Aballi S, Ghanima W.

Serum proteomics in COVID-19 patients: Altered coagulation and complement status as a function of IL-6 level

D'Alessandro A, Thomas T, Dzieciatkowska M, Hill RC, Francis RO, Hudson KE, Zimring JC, Hod EA, Spitalnik SL, Hansen KC.

Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19

Horowitz NA, Brenner B.

Can fibrinolytic therapy be clinically useful in severe pneumonia caused by COVID-19?

Bornstein R, P√°ramo JA.

Catheter-directed thrombolysis to treat acute pulmonary thrombosis in a patient with COVID-19 pneumonia

Pendower L, Benedetti G, Breen K, Karunanithy N.

Extensive cerebral venous sinus thrombosis: a potential complication in a patient with COVID-19 disease

Bolaji P, Kukoyi B, Ahmad N, Wharton C.

Thrombolysis and use of argatroban for the treatment of massive pulmonary embolism following anticoagulation failure in a patient with COVID-19

Sagardia LM, Daniels LM.

Development of pulmonary embolism in a nonhospitalized patient with COVID-19 who did not receive venous thromboembolism prophylaxis

Uppuluri EM, Shapiro NL.

The differing pathophysiologies that underlie COVID-19 associated perniosis and thrombotic retiform purpura: a case series

Magro C, Mulvey JJ, Laurence J, Sanders S, Crowson N, Grossman M, Harp J, Nuovo G.

Covid-19-induced coagulopathy and observed benefits with anticoagulation

Karimzadeh S, Dong V, Hassan OG, Raut A, Fouda A, Parrill A, Eaton K, Huy NT.

D-dimer level is associated with the severity of COVID-19

Yu HH, Qin C, Chen M, Wang W, Tian DS.

Vascular inflammation and endothelial injury in SARS-CoV-2 infection: The overlooked regulatory cascades implicated by the ACE2 gene cluster

Shovlin CL, Vizcaychipi MP.

Systemic Inflammatory Response Syndrome Is a Major Contributor to COVID-19-Associated Coagulopathy: Insights From a Prospective, Single-Center Cohort Study

Masi P, Hékimian G, Lejeune M, Chommeloux J, Desnos C, Pineton De Chambrun M, Martin-Toutain I, Nieszkowska A, Lebreton G, Bréchot N, Schmidt M, Edouard Luyt C, Combes A, Frere C.

COVID-19 related immune hemolysis and thrombocytopenia

Sahu KK, Borogovac A, Cerny J.

Percutaneous Mechanical Pulmonary Thrombectomy in a Patient With Pulmonary Embolism as a First Presentation of COVID-19

Hoilat GJ, Durer C, Durer S, Gupta P.

Successful aspiration thrombectomy in a patient with submassive, intermediate-risk pulmonary embolism following COVID-19 pneumonia

Pohlan J, Kamel SN, Torsello GF, Zickler D, Kruse JM, Eckardt KU, Gebauer B.

More than Just Pneumonia: Acute Pulmonary Embolism in Two Middle-Aged Patients with COVID-19

Mazo J, Singh S, Khan Z, Foster A, Komarnitsky E, Nagaraj A, Patel S, Kikkeri V.

Evaluation of coagulation status using viscoelastic testing in intensive care patients with coronavirus disease 2019 (COVID-19): An observational point prevalence cohort study

Collett LW, Gluck S, Strickland RM, Reddi BJ.

Thrombus in the right atrium after COVID-19 pneumonia

Alcoberro Torres L, Claver Garrido E, Moliner Borja P.

Pulmonary Embolism in Patients With Covid-19 Pneumonia: The Utility of D-dimer

Rodriguez-Sevilla J, Rodó-Pin A, Espallargas I, Villar-García J, Molina L, Pérez Terán P, Vázquez Sanchez A, Masclans JR, Jiménez C, Millan Segovia R, Zuccarino F, Salar A, Rodriguez-Chiaradía DA.

Thromboembolic events and Covid-19

Ribes A, Vardon-Bounes F, Mémier V, Poette M, Au-Duong J, Garcia C, Minville V, Sié P, Bura-Rivière A, Voisin S, Payrastre B.

Pulmonary arterial thrombosis as an important complication of COVID-19 pulmonary disease: letter to the editor

Lax SF, Skok K, Trauner M; all coauthors.

Antiplatelet/anticoagulant agents for preventing thrombosis events in patients with severe COVID-19: A protocol for systematic review and meta-analysis

Li Y, Xu Y, Shi P, Zhu Y, Hu W, Chen C.

Fibrinolysis Shutdown and Thrombosis in A COVID-19 ICU

Creel-Bulos C, Auld SC, Caridi-Scheible M, Barker N, Friend S, Gaddh M, Kempton CL, Maier C, Nahab F, Sniecinski R.

Immunity, inflammation and the vasculature in the COVID-19 era

Schutte AE, Harrison DG.

Spontaneous Major Hemorrhage in COVID-19 Patients: Another Brick in the Wall of SARS-CoV-2-Associated Coagulation Disorders?

Palumbo D, Guazzarotti G, De Cobelli F.

Large sacral/buttocks ulcerations in the setting of coagulopathy: A case series establishing the skin as a target organ of significant damage and potential morbidity in patients with severe COVID-19

Young S, Narang J, Kumar S, Kwizera E, Malik P, Billings SD, Ko JS, Fernandez AP.

Acute myocardial infarction and large coronary thrombosis in a patient with COVID-19

Tedeschi D, Rizzi A, Biscaglia S, Tumscitz C.

Post-discharge thrombosis and hemorrhage in patients with COVID-19

Patell R, Bogue T, Koshy AG, Bindal P, Merrill M, Aird WC, Bauer KA, Zwicker JI.

Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series

Rapkiewicz AV, Mai X, Carsons SE, Pittaluga S, Kleiner DE, Berger JS, Thomas S, Adler NM, Charytan DM, Gasmi B, Hochman JS, Reynolds HR.

Prominent Hypercoagulability Associated With Inflammatory State Among Cancer Patients With SARS-CoV-2 Infection

Xiong B, Liu T, Luo P, Wei Y, Zhou Y, Liu M, Zhang Y, Wang H, Zhang X, Wang X, Zhou F.

Dynamic Interleukin-6 Level Changes as a Prognostic Indicator in Patients With COVID-19

Liu Z, Li J, Chen D, Gao R, Zeng W, Chen S, Huang Y, Huang J, Long W, Li M, Guo L, Wang X, Wu X.

Thrombolysis in severe COVID-19 pneumonia with massive pulmonary embolism

Alharthy A, Faqihi F, Papanikolaou J, Balhamar A, Blaivas M, Memish ZA, Karakitsos D.

Narrowing in on the True Rate of Venous Thromboembolism in Hospitalized Patients With COVID-19 Disease

Siegal DM, Gross PL.

Endothelial Dysfunction and Thrombosis in Patients With COVID-19

Nagashima S, Mendes MC, Camargo Martins AP, Borges NH, Godoy TM, Miggiolaro AFRDS, da Silva Dezidério F, Machado-Souza C, de Noronha L.

[Coagulation dysfunction in COVID-19]

Xu Y, Lyu D, Ying K.

In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation

Blasi A, von Meijenfeldt FA, Adelmeijer J, Calvo A, Ibañez C, Perdomo J, Carlos Reverter J, Lisman T.

Is the COVID-19 thrombotic catastrophe complement-connected?

Conway EM, Pryzdial ELG.

Large vessel stroke in six patients following SARS-CoV-2 infection: a retrospective case study series of acute thrombotic complications on stable underlying atherosclerotic disease

Lapergue B, Lyoubi A, Meseguer E, Avram I, Denier C, Venditti L, Consoli A, Guedon A, Houdart E, Weisenburger-Lile D, Piotin M, Maier B, Obadia M, De Broucker T.

Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19

Liu Y, Gao W, Guo W, Guo Y, Shi M, Dong G, Ge Q, Zhu J, Lu J.

Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis

Skendros P, Mitsios A, Chrysanthopoulou A, Mastellos DC, Metallidis S, Rafailidis P, Ntinopoulou M, Sertaridou E, Tsironidou V, Tsigalou C, Tektonidou MG, Konstantinidis T, Papagoras C, Mitroulis I, Germanidis G, Lambris JD, Ritis K.

Biomarkers of Platelet Activity and Vascular Health Associate with Thrombosis and Mortality in Patients with COVID-19

Barrett TJ, Lee A, Xia Y, Lin LH, Black M, Cotzia P, Hochman JS, Berger JS.

Acute peripheral arterial thrombosis in COVID-19. Role of endothelial inflammation

Gonzalez Cañas E, Gimenez Gaibar A, Rodriguez Lorenzo L, Castro Rios JG, Martinez Toiran A, Bella Cueto MR, Bella Burgos B, Espasa Soley M.

Applicability of bedside ultrasonography for the diagnosis of deep venous thrombosis in patients with COVID-19 and treatment with low molecular weight heparin

Zhang P, Qu Y, Tu J, Cao W, Hai N, Li S, Qu P, Lv C, Guo R.

Long lasting hypercoagulability after subclinical COVID-19

Ferroli P, Villa C, Ciuffi A, Gubertini G, Broggi M.

Livedoid and Purpuric Skin Eruptions Associated With Coagulopathy in Severe COVID-19

Droesch C, Hoang M, DeSancho M, Lee EJ, Magro C, Harp J.

Venous Thromboembolism among Hospitalized Patients with COVID-19 Undergoing Thromboprophylaxis: A Systematic Review and Meta-Analysis

Chi G, Lee JJ, Jamil A, Gunnam V, Najafi H, Memar Montazerin S, Shojaei F, Marszalek J.

D-dimer surge and coagulation disorders in COVID-19 related pneumonia patients with cardiac injury: A case series

Wang X, Du B, Li J, Wang S, Wang X, Guo M, Yang B, Si D, Bai O.

Immunothrombotic Dysregulation in COVID-19 Pneumonia is Associated with Respiratory Failure and Coagulopathy

Nicolai L, Leunig A, Brambs S, Kaiser R, Weinberger T, Weigand M, Muenchhoff M, Hellmuth JC, Ledderose S, Schulz H, Scherer C, Rudelius M, Zoller M, Höchter D, Keppler O, Teupser D, Zwißler B, Bergwelt-Baildon M, Kääb S, Massberg S, Pekayvaz K, Stark K.

Multisystem assessment of the imaging manifestations of coagulopathy in hospitalized patients with COVID-19

O'Shea A, Parakh A, Hedgire S, Lee SI.

Coronary thrombosis in a young male with COVID-19

Shams A, Ata F, Mushtaq K, Munir W, Yousaf Z.

Hypercoagulable State in COVID-19: A Case Series of Three Patients

Logan G, Dub L, Drone E, Ganti L, Webb AL.

Emotions and Opinions of Adult Patients with Haemophilia During the COVID-19 (Coronavirus Disease 2019) Pandemic Caused by SARS-CoV-2: A Monocentric Survey

Napolitano M, Mansueto MF, Sirocchi D, Contrino AD, Raso S, Siragusa S.

Prevention of Venous Thromboembolism in 2020 and Beyond

Nicholson M, Chan N, Bhagirath V, Ginsberg J.

COVID-19-Related Coagulopathy-Is Transferrin a Missing Link?

McLaughlin KM, Bechtel M, Bojkova D, Münch C, Ciesek S, Wass MN, Michaelis M, Cinatl J Jr.

COVID-19 coagulopathy: an in-depth analysis of the coagulation system

Martín-Rojas RM, Pérez-Rus G, Delgado-Pinos VE, Domingo-González A, Regalado-Artamendi I, Alba-Urdiales N, Demelo-Rodríguez P, Monsalvo S, Rodríguez-Macías G, Ballesteros M, Osorio-Prendes S, Díez-Martín JL, Pascual C.

Current Overview on Hypercoagulability in COVID-19

Singhania N, Bansal S, Nimmatoori DP, Ejaz AA, McCullough PA, Singhania G.

COVID-19: The crucial role of blood coagulation and fibrinolysis

Coccheri S.

Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis

Hasan SS, Radford S, Kow CS, Zaidi STR.

Post-discharge venous thromboembolism following hospital admission with COVID-19

Roberts LN, Whyte MB, Georgiou L, Giron G, Czuprynska J, Rea C, Vadher B, Patel R, Gee E, Arya R.

Vascular occlusion by neutrophil extracellular traps in COVID-19

Leppkes M, Knopf J, Naschberger E, Lindemann A, Singh J, Herrmann I, Stürzl M, Staats L, Mahajan A, Schauer C, Kremer AN, Völkl S, Amann K, Evert K, Falkeis C, Wehrfritz A, Rieker RJ, Hartmann A, Kremer AE, Neurath MF, Muñoz LE, Schett G, Herrmann M.

Pulmonary Embolism in COVID-19 Pneumonia: Random Association or Causality?

Fortuzi K, Ghazanfar H, Haider A, Patel K, Patel M.

Major Thrombotic Event Despite Anticoagulation in a Patient With COVID-19

Ataallah B, Sharma A, Tamanna S, Ng J, Haggerty G.

Thrombosis and Coagulopathy in COVID-19 Patients Requiring Extracorporeal Membrane Oxygenation

Yusuff H, Zochios V, Brodie D.

COVID-19 associated coagulopathy and inflammatory response: what do we know already and what are the knowledge gaps?

Görlinger K, Dirkmann D, Gandhi A, Simioni P.

Multiple thromboemboli in Covid-19

Ufuk F.

Utility of D-dimer for diagnosis of deep vein thrombosis in COVID-19 infection

Cho ES, McClelland PH, Cheng O, Kim Y, Hu J, Zenilman ME, D'Ayala M.

Femoral arterial thrombosis in a young adult following non-severe COVID-19

Veyre F, Poulain-Veyre C, Esparcieux A, Monsarrat N, Aouifi A, Lapeze J, Chatelard P.

Thrombolysis restores perfusion in COVID 19 hypoxia

Arachchillage DJ, Stacey A, Akor F, Scotz M, Laffan M.

The vascular nature of COVID-19

Oudkerk M, Kuijpers D, Oudkerk SF, van Beek EJ.

Pulmonary thromboembolism in hospitalised COVID-19 patients at moderate to high risk by Wells score: a report from Lombardy, Italy

Monfardini L, Morassi M, Botti P, Stellini R, Bettari L, Pezzotti S, Alì M, Monaco CG, Magni V, Cozzi A, Schiaffino S, Bnà C.

Papillophlebitis in a COVID-19 patient: Inflammation and hypercoagulable state

Insausti-García A, Reche-Sainz JA, Ruiz-Arranz C, López Vázquez Á, Ferro-Osuna M.

COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response

Jayarangaiah A, Kariyanna PT, Chen X, Jayarangaiah A, Kumar A.

Saddle pulmonary embolism and thrombus-in-transit straddling the patent foramen ovale 28 days after COVID symptom onset

Fujikura K, Fontes JD, Taub CC.

Association between Pulmonary Embolism and COVID-19 in ED patients Undergoing CTPA: the PEPCOV international retrospective study

Freund Y, Drogrey M, Miró Ò, Marra A, Féral-Pierssens AL, Penaloza A, Lara Hernandez BA, Beaune S, Gorlicki J, Vattinada Ayar P, Truchot J, Pena B, Aguirre A, Fémy F, Javaud N, Chauvin A, Chouihed T, Montassier E, Claret PG, Occelli C, Roussel M, Brigant F, Ellouze S, Le Borgne P, Laribi S, Simon T, Lucidarme O, Cachanado M, Bloom B; IMPROVING EMERGENCY CARE FHU Collaborators.

Concerns for management of STEMI patients in the COVID-19 era: a paradox phenomenon

Vlachakis PK, Tentolouris A, Kanakakis I.

Complement Inhibition in Coronavirus Disease (COVID)-19: A Neglected Therapeutic Option

Stahel PF, Barnum SR.

Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications

Merrill JT, Erkan D, Winakur J, James JA.

Pulmonary Thromboembolism in Patient with COVID-19 after Breast Reconstruction

Siotos C, Doscher ME, Hasan JS, Grevious MA.

The Roles of GRKs in Hemostasis and Thrombosis

Chen X, Zhao X, Cooper M, Ma P.

Feasibility of Bedside Ultrasound-Guided Inferior Vena Cava Filter Implantation in COVID-19 Patients with Deep Venous Thrombosis

Li Y, Deng J, Liao J, Li H, Wang W, Zhang D, Wang J, Zhang L, Xie M.

Multiple spontaneous coronary thrombosis causing ST-elevation myocardial infarction in a patient with COVID-19

Kurdi H, Obaid DR, UlHaq Z, Ionescu A, Sekar B.

Thrombocytopenia in COVID-19 patients in Himachal Pradesh (India) and the absence of dengue false positive tests: Insights for patient management

Bansal N, Bansal Y, Ralta A.

[Thrombotic complication of severe COVID-19 pneumonia: stroke due to atypical paradoxical embolism]

Ballvé-Martín A, Boned S, Rubiera M.

Hypoxia - an overlooked trigger for thrombosis in COVID-19 and other critically ill patients

Thachil J.

Characteristics of Acute Pulmonary Embolism in Patients With COVID-19 Associated Pneumonia From the City of Wuhan

Chen J, Wang X, Zhang S, Lin B, Wu X, Wang Y, Wang X, Yang M, Sun J, Xie Y.

COVID-19 and Hypercoagulability: Potential Impact on Management with Oral Contraceptives, Estrogen Therapy and Pregnancy

Spratt DI, Buchsbaum RJ.

Superior Mesenteric Artery Thrombosis and Acute Intestinal Ischemia as a Consequence of COVID-19 Infection

Cheung S, Quiwa JC, Pillai A, Onwu C, Tharayil ZJ, Gupta R.

A comprehensive assessment of the coagulation profile in critically ill COVID-19 patients

Adam EH, Zacharowski K, Miesbach W.

A Rare Finding of Upper Limb Deep Venous Thrombosis in a Patient with COVID-19

Lal S, Lal S, Hashmi J.

COVID-19: disCOVering the role of complement system

Conigliaro P, Triggianese P, Perricone C, Chimenti MS, Perricone R.

Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications

Haimei MA.

Heparin-Induced Thrombocytopenia in COVID-19

Lingamaneni P, Gonakoti S, Moturi K, Vohra I, Zia M.

[Steroid pulse -therapy in patients With coronAvirus Pneumonia (COVID-19), sYstemic inFlammation And Risk of vEnous thRombosis and thromboembolism (WAYFARER Study)]

Mareev VY, Orlova YA, Pavlikova EP, Matskeplishvili ST, Krasnova TN, Malahov PS, Samokhodskaya LM, Mershina EA, Sinitsyn VE, Mareev YV, Kalinkin AL, Begrambekova YL, Kamalov AA.

Extensive coronary artery thrombosis complicating COVID-19 infection and haemophagocytic lymphohistiocytosis

Dancy LH, Abu-Own H, Byrne J, Pareek N.

Incidence and mortality of pulmonary embolism in COVID-19: a systematic review and meta-analysis

Liao SC, Shao SC, Chen YT, Chen YC, Hung MJ.

Bilateral Acute Cardioembolic Limb Ischemia After Coronavirus Disease 2019 Pneumonia in a Lung Transplant Recipient: A Case Report

Renaud-Picard B, Gallais F, Ohana M, Zeyons F, Kretz B, Andre J, Sattler L, Hirschi S, Kessler R.

Diagnostic performance of initial blood urea nitrogen combined with D-Dimer levels for predicting in-hospital mortality in COVID-19 patients

Cheng A, Hu L, Wang Y, Huang L, Zhao L, Zhang C, Liu X, Xu R, Liu F, Li J, Ye D, Wang T, Lv Y, Liu Q.

COVID-19 infection and Thrombosis

Srivastava S, Garg I, Bansal A, Kumar B.

Venous Thromboembolism in COVID-19 ICU Patients

Moll M, Zon RL, Sylvester KW, Chen EC, Cheng V, Connell NT, Fredenburgh LE, Baron RM, Cho MH, Woolley AE, Connors JM.

Hypoxia and Thrombosis in COVID-19: New Considerations for Air Passengers

Parker S, Mahomed O.

Should the search for COVID-19 become part of the work-up of incidental thromboembolism? A near-missed COVID-19 diagnosis

Franceschini M, Carlin M, Porta M, Brizzi MF.

Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis

Moriarty PM, Gorby LK, Stroes ES, Kastelein JP, Davidson M, Tsimikas S.

Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes

Grobler C, Maphumulo SC, Grobbelaar LM, Bredenkamp JC, Laubscher GJ, Lourens PJ, Steenkamp J, Kell DB, Pretorius E.

Venous thromboembolism in non-critically ill patients with COVID-19 infection

Trimaille A, Curtiaud A, Marchandot B, Matsushita K, Sato C, Leonard-Lorant I, Sattler L, Grunebaum L, Ohana M, Von Hunolstein JJ, Andres E, Goichot B, Danion F, Kaeuffer C, Poindron V, Ohlmann P, Jesel L, Morel O.

COVID-19 and Coagulation Dysfunction in Adults: A Systematic Review and Meta-analysis

Lin J, Yan H, Chen H, He C, Lin C, He H, Zhang S, Shi S, Lin K.

Coagulation dysfunction is associated with severity of COVID-19: a meta-analysis

Zhu J, Pang J, Ji P, Zhong Z, Li H, Li B, Zhang J, Lu J.

Acute thrombotic events as initial presentation of patients with COVID-19 infection

Ilonzo N, Rao A, Berger K, Phair J, Vouyouka A, Ravin R, Han D, Finlay D, Tadros R, Marin M, Faries P.

Arterial thromboembolism associated with COVID-19 and elevated D-dimer levels

Garg K, Barfield ME, Pezold ML, Sadek M, Cayne NS, Lugo J, Maldonado TS, Berland TL, Rockman CB, Jacobowitz GR.

Cerebral venous sinus thrombosis might be under-diagnosed in the COVID-19 era

Shakibajahromi B, Borhani-Haghighi A, Haseli S, Mowla A.

Complement C5 inhibition in patients with COVID-19 - a promising target?

Peffault de Latour R, Bergeron A, Lengline E, Dupont T, Marchal A, Galicier L, de Castro N, Bondeelle L, Darmon M, Dupin C, Dumas G, Leguen P, Madelaine I, Chevret S, Molina JM, Azoulay E, Fremeaux-Bacchi V; CORE GROUP.

Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients

Ahmed SI, Khan S.

Coagulation Status and Venous Thromboembolism Risk in African Americans: A Potential Risk Factor in COVID-19

Frydman GH, Boyer EW, Nazarian RM, Van Cott EM, Piazza G.

COVID-19 coagulopathy, thrombosis, and bleeding

Chan NC, Weitz JI.

Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System

Bilaloglu S, Aphinyanaphongs Y, Jones S, Iturrate E, Hochman J, Berger JS.

Disseminated Intravascular Coagulation: A Devastating Systemic Disorder of Special Concern with COVID-19

Singh P, Schwartz RA.

Lung scintigraphy for pulmonary embolism diagnosis during the COVID-19 pandemic: does the benefit-risk ratio really justify omitting the ventilation study?

Le Roux PY, Le Gal G, Salaun PY.

COVID-19-associated vasculitis and vasculopathy

Becker RC.

COVID-19: Complement, Coagulation, and Collateral Damage

Lo MW, Kemper C, Woodruff TM.

Pulmonary Embolism, Pulmonary Microvascular Thrombosis, or Both in COVID-19?

P√°ramo JA.

Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review

Hayıroğlu Mİ, Çınar T, Tekkeşin Aİ.

Thrombosis and anticoagulation in COVID-19

Ramos RP, Ota-Arakaki JS.

Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic

Marchandot B, Trimaille A, Curtiaud A, Matsushita K, Jesel L, Morel O.

SARS-CoV-2 induced thrombocytopenia as an important biomarker significantly correlated with abnormal coagulation function, increased intravascular blood clot risk and mortality in COVID-19 patients

Bao C, Tao X, Cui W, Yi B, Pan T, Young KH, Qian W.

Multiple Thrombotic Events in a 67-Year-Old Man 2 Weeks After Testing Positive for SARS-CoV-2: A Case Report

Shawkat A, Merrell ET, Fadel GA, Amzuta I, Amin H, Shah AJ, Habeb H, Aiash H.

Portal Vein Thrombosis in a Patient With COVID-19

Ofosu A, Ramai D, Novikov A, Sushma V.

Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?

Ladikou EE, Sivaloganathan H, Milne KM, Arter WE, Ramasamy R, Saad R, Stoneham SM, Philips B, Eziefula AC, Chevassut T.

Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology

Vivas D, Roldán V, Esteve-Pastor MA, Roldán I, Tello-Montoliu A, Ruiz-Nodar JM, Cosín-Sales J, Gámez JM, Consuegra L, Ferreiro JL, Marín F; Expert reviewers.

Multifactorial pathogenesis of COVID-19-related coagulopathy. Can defibrotide have a role in the early phases of coagulation disorders?

Macciò A, Madeddu C, Caocci G, La Nasa G.

Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID-19

Patell R, Bogue T, Bindal P, Koshy A, Merrill M, Aird WC, Bauer KA, Zwicker JI.

Hypoalbuminemia and elevated D-dimer in COVID-19 patients: a call for result harmonization

Aloisio E, Serafini L, Chibireva M, Dolci A, Panteghini M.

Clinical findings, risk factors, and final outcome in patients diagnosed with pulmonary thromboembolism and COVID-19 in hospital emergency departments

Jiménez Hernández S, Lozano Polo L, Suñen Cuquerella G, Peña Pardo B, Espinosa B, Cardozo C, Aguirre Tejedo A, Llorens Soriano P, Miró Ò.

ACE2 down-regulation may contribute to the increased thrombotic risk in COVID-19

Lupi L, Adamo M, Inciardi RM, Metra M.

COVID-19 induced systemic thrombosis

Fulgencio-Barbarin J, Calleja-Algarra A, Morales-Raya C.

Cerebral venous thrombosis: A typical presentation of COVID-19 in the young

Klein DE, Libman R, Kirsch C, Arora R.

Hemorrhagic stroke and anticoagulation in COVID-19

Dogra S, Jain R, Cao M, Bilaloglu S, Zagzag D, Hochman S, Lewis A, Melmed K, Hochman K, Horwitz L, Galetta S, Berger J.

Viral Coagulopathy in Patients With COVID-19: Treatment and Care

Kipshidze N, Dangas G, White CJ, Kipshidze N, Siddiqui F, Lattimer CR, Carter CA, Fareed J.

Thrombosis centres and AVKs monitoring in COVID-19 pandemic

Barcellona D, Marongiu F.

The underrecognized prothrombotic vascular disease of COVID-19

Cohoon KP, Mahé G, Spyropoulos AC.

Heparin-induced thrombocytopenia with thrombosis in COVID-19 adult respiratory distress syndrome

Riker RR, May TL, Fraser GL, Gagnon DJ, Bandara M, Zemrak WR, Seder DB.

Venous thromboembolism in critically Ill patients with COVID-19: Results of a screening study for deep vein thrombosis

Longchamp A, Longchamp J, Manzocchi-Besson S, Whiting L, Haller C, Jeanneret S, Godio M, Garcia Martinez JJ, Bonjour T, Caillat M, Maitre G, Thaler JM, Pantet R, Donner V, Dumoulin A, Emonet S, Greub G, Friolet R, Robert-Ebadi H, Righini M, Sanchez B, Delaloye J.

Pulmonary embolism during the COVID-19 pandemic: Decline in diagnostic procedures and incidence at a university hospital

Nopp S, Janata-Schwatczek K, Prosch H, Shulym I, Königsbrügge O, Pabinger I, Ay C.

Thrombosis and coagulopathy in COVID-19: An illustrated review

Levi M, Hunt BJ.

Thrombosis and thromboembolism related to COVID-19: A clarion call for obtaining solid estimates from large-scale multicenter data

Barco S, Konstantinides SV; CORE‚ÄêTHROMBOSIS Investigators.

Potential role of platelets in COVID-19: Implications for thrombosis

Koupenova M.

A proposal for staging COVID-19 coagulopathy

Thachil J, Cushman M, Srivastava A.

Staying updated on COVID-19: Social media to amplify science in thrombosis and hemostasis

Makris M.

Gender gap in women authors is not worse during COVID-19 pandemic: Results from Research and Practice in Thrombosis and Haemostasis

Cushman M.

D-dimer as an indicator of prognosis in SARS-CoV-2 infection: a systematic review

Vidali S, Morosetti D, Cossu E, Luisi MLE, Pancani S, Semeraro V, Consales G.

A Case Report of Polymerase Chain Reaction-Confirmed COVID-19 in a Patient With Right Ventricular Thrombus and Bilateral Deep Vein Thrombosis

Elkattawy S, Younes I, Noori MAM.

A case of non-severe COVID-19 complicated by pulmonary embolism

Akiyama Y, Horiuchi K, Kondo Y, Kabata H, Ishii M, Fukunaga K.

Thrombocytopenia in COVID-19: pathophysiology matters

Gavriilaki E, Sakellari I, Gavriilaki M, Anagnostopoulos A.

COVID-19-associated coagulopathy

Franchini M, Marano G, Cruciani M, Mengoli C, Pati I, Masiello F, Veropalumbo E, Pupella S, Vaglio S, Liumbruno GM.

Cerebral hemorrhage related to vein thrombosis in Covid-19 patients in different Italian hospitals: View point for clinical and imaging implications

Argirò R, Cirelli C, Sgreccia A, Del Sette B, Da Ros V.

Microthrombosis Associated with Gastrointestinal Bleeding in COVID-19

Buckholz A, Kaplan A, Jessurun J, De Jong Y, Crawford C.

Screening of COVID-19-associated hypercoagulopathy using rotational thromboelastometry

Iwasaki Y, Shiga T, Konno D, Saito K, Aoyagi T, Oshima K, Kanamori H, Baba H, Tokuda K, Yamauchi M.

Pulmonary embolism in hospitalised patients with COVID-19

Whyte MB, Kelly PA, Gonzalez E, Arya R, Roberts LN.

Coagulopathy in COVID-19: Focus on vascular thrombotic events

Shi W, Lv J, Lin L.

Hemostatic Changes in Patients with COVID-19: A Meta-Analysis with Meta-Regressions

Di Minno MND, Calcaterra I, Lupoli R, Storino A, Spedicato GA, Maniscalco M, Di Minno A, Ambrosino P.

Personalizing Antithrombotic Therapy in COVID-19: Role of Thromboelastography and Thromboelastometry

Chaudhary R, Kreutz RP, Bliden KP, Tantry US, Gurbel PA.

Prevalence and Impact of Coagulation Dysfunction in COVID-19 in China: A Meta-Analysis

Jin S, Jin Y, Xu B, Hong J, Yang X.

High Thrombus Burden in Patients with COVID-19 Presenting with ST-Elevation Myocardial Infarction

Choudry FA, Hamshere SM, Rathod KS, Akhtar MM, Archbold RA, Guttmann OP, Woldman S, Jain AK, Knight CJ, Baumbach A, Mathur A, Jones DA.

Clinical characteristics, management and outcome of Covid-19-associated immune thrombocytopenia. A French multicenter series

Mahévas M, Moulis G, Andres E, Riviere E, Garzaro M, Crickx E, Guillotin V, Malphettes M, Galicier L, Noel N, Darnige L, Terriou L, Guerveno C, Sanchis-Borja M, Moulinet T, Meunier B, Ebbo M, Michel M, Godeau B.

A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19

D'Souza R, Malhamé I, Teshler L, Acharya G, Hunt BJ, McLintock C.

Platelet activation and platelet-monocyte aggregates formation trigger tissue factor expression in severe COVID-19 patients

Hottz ED, Azevedo-Quintanilha IG, Palhinha L, Teixeira L, Barreto EA, P√£o CRR, Righy C, Franco S, Souza TML, Kurtz P, Bozza FA, Bozza PT.

Microthrombi and ST-Segment Elevation Myocardial Infarction in COVID-19

Guagliumi G, Sonzogni A, Pescetelli I, Pellegrini D, Finn AV.

COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation

Miesbach W, Makris M.

Immune thrombocytopenia in a patient with COVID-19

Deruelle E, Ben Hadj Salem O, Sep Hieng S, Pichereau C, Outin H, Jamme M.

COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness

Du F, Liu B, Zhang S.

How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report

Zanon E, Pasca S, Campello E, Spiezia L, Vettor R, Simioni P.

Unique transcriptional changes in coagulation cascade genes in SARS-CoV-2-infected lung epithelial cells: A potential factor in COVID-19 coagulopathies

FitzGerald ES, Jamieson AM.

Immune Thrombocytopenia Purpura Secondary to COVID-19

Bennett J, Brown C, Rouse M, Hoffmann M, Ye Z.

Research in brief: Coagulopathy in COVID-19: Determining and managing thrombotic risk in COVID-19 infection

Pooni RS.

Lessons of the month 3: ST-elevation myocardial infarction and left ventricular thrombus formation: an arterial thrombotic complication of severe COVID-19 infection

Fenton M, Siddavaram S, Sugihara C, Husain S.

Thrombocytopenia in pregnant patients with mild COVID-19

Le Gouez A, Vivanti AJ, Benhamou D, Desconclois C, Mercier FJ.

Characteristics of venous thromboembolism in COVID-19 patients: a multicenter experience from Northern Italy

Marone EM, Bonalumi G, Curci R, Arzini A, Chierico S, Marazzi G, Diaco DA, Rossini R, Boschini S, Rinaldi LF.

Lower extremity arterial thrombosis associated with COVID-19 is characterized by greater thrombus burden and increased rate of amputation and death

Goldman IA, Ye K, Scheinfeld MH.

High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?

Ibañez C, Perdomo J, Calvo A, Ferrando C, Reverter JC, Tassies D, Blasi A.

Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies

Allegra A, Innao V, Allegra AG, Musolino C.

Coronavirus Disease 2019 (COVID-19)-Associated Thromboembolic Disease: A Report of Three Patients With Pulmonary Embolism

Guccione J, Ocazionez D, Aisenberg G, Odisio E.

COVID-19: A Potential Risk Factor for Acute Pulmonary Embolism

Martin AI, Rao G.

Microthrombotic Complications of COVID-19 Are Likely Due to Embolism of Circulating Endothelial Derived Ultralarge von Willebrand Factor (eULVWF) Decorated-Platelet Strings

Varatharajah N, Rajah S.

Axillary vein thrombosis in COVID positive patient with midline and continuous positive airway pressure Helmet

Vailati D, Fusco T, Canelli A, Chiariello C, Zerla P.

Hypofibrinolytic state and high thrombin generation may play a major role in sars-cov2 associated thrombosis

Nougier C, Benoit R, Simon M, Desmurs-Clavel H, Marcotte G, Argaud L, David JS, Bonnet A, Negrier C, Dargaud Y.

coagulation profile in severe COVID-19 patients: what do we know so far?

Savioli F, Rocha LL.

Images in Vascular Medicine: Peripheral artery thrombosis in critically ill patients with COVID-19

Tutar N, Baran Ketencioglu B, Temel Ş, Gündoğan K, Karabıyık Ö, Sungur M.

Late Pulmonary Embolism after COVID-19 Pneumonia despite Adequate Rivaroxaban Treatment

Di Tano G, Moschini L, Loffi M, Testa S, Danzi GB.

Immune Thrombocytopenic Purpura in Patients with COVID-19

Revuz S, Vernier N, Saadi L, Campagne J, Poussing S, Maurier F.

Can Lung Ultrasound be Used to Screen for Pulmonary Embolism in Patients with SARS-CoV-2 Pneumonia?

Boccatonda A, Ianniello E, D'Ardes D, Cocco G, Giostra F, Borghi C, Schiavone C.

D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study

Yao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z, Chen X, Chen S, Yu K, Huang Z, Hu B.

Elevated D-Dimer Levels are Associated with Increased Risk of Mortality in COVID-19: A Systematic Review and Meta-Analysis

Shah S, Shah K, Patel SB, Patel FS, Osman M, Velagapudi P, Turagam MK, Lakkireddy D, Garg J.

Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?

Siguret V, Voicu S, Neuwirth M, Delrue M, Gayat E, Stépanian A, Mégarbane B.

COVID-19-associated coagulopathy - Hypothesis: Are Children protected due to enhanced thrombin inhibition by higher α(2) -Macroglobulin (α2-M)?

Schramm W, Seitz R, Gürtler L.

Hematolological Manifestations of COVID-19: From Cytopenia to Coagulopathy

Agbuduwe C, Basu S.

Systemic fibrinolysis for acute pulmonary embolism complicating acute respiratory distress syndrome in severe COVID-19: a case series

Bona RD, Valbusa A, Malfa G, Giacobbe DR, Ameri P, Patroniti N, Robba C, Gilad V, Insorsi A, Bassetti M, Pelosi P, Porto I; GECOVID study group.

Impact of the COVID-19 pandemic on hyperacute stroke treatment: experience from a comprehensive stroke centre in Singapore

Paliwal PR, Tan BYQ, Leow AST, Sibi S, Chor DWP, Chin AXY, Yau YW, Cross GB, Wong LYH, Chia MLJ, Quak Z, Chua CYK, Tang DKK, Zune ET, Hung J, Goh Y, Jing M, Gopinathan A, Yang C, Ahmad A, Khoo DXL, Lee CM, Seet RCS, Sharma VK, Teoh HL, Yeo LLL, Chan BPL.

COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature

Tan YK, Goh C, Leow AST, Tambyah PA, Ang A, Yap ES, Tu TM, Sharma VK, Yeo LLL, Chan BPL, Tan BYQ.

Coagulopathy in COVID-19 infection: a case of acute upper limb ischemia

Galanis N, Stavraka C, Agathangelidis F, Petsatodis E, Giankoulof C, Givissis P.

Bivalirudin for Maintenance Anticoagulation During Venovenous Extracorporeal Membrane Oxygenation for COVID-19

Seelhammer TG, Rowse P, Yalamuri S.

Coronavirus disease 2019 (COVID-19) associated coagulopathy and its impact on outcomes in Shenzhen, China: A retrospective cohort study

Luan YY, Liu Y, Liu XY, Yu BJ, Chen RL, Peng M, Ren D, Li HL, Huang L, Liu Y, Li JX, Feng YW, Wu M.

Coagulation disorder in COVID-19

Kander T.

Is the Reason of Increased D-Dimer Levels in COVID-19 Because of ACE-2-Induced Apoptosis in Endothelium?

Guler N, Siddiqui F, Fareed J.

[Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina]

Vazquez FJ, Korin J, Baldessari EM, Capparelli FJ, Gutierrez P, Pale C, Bocanegra F, Grand B, Penchasky D, Gonzalez Alcántara MM, Prémoli MS, Tabares A, Wainsztein N, Odetto D, Vaccaro C, Martínez Aquino E, Cumpian O, Falabella V, Antuel García S, Saadi J, Siccardi M, Gándara E.

Correction to: Deep Vein Thrombosis in Hospitalized Patients With COVID-19 in Wuhan, China: Prevalence, Risk Factors, and Outcome

Hospitalized COVID-19 Patients and Venous Thromboembolism: A Perfect Storm

Spyropoulos AC, Weitz JI.

Heparin induced thrombocytopenia antibodies in COVID-19

Patell R, Khan A, Bogue T, Merrill M, Koshy A, Bindal P, Joyce R, Aird WC, Neuberg D, Bauer KA, Zwicker JI.

Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses

Mackman N, Antoniak S, Wolberg AS, Kasthuri R, Key NS.

Pulmonary embolism in COVID-19 patients: a French multicentre cohort study

Fauvel C, Weizman O, Trimaille A, Mika D, Pommier T, Pace N, Douair A, Barbin E, Fraix A, Bouchot O, Benmansour O, Godeau G, Mecheri Y, Lebourdon R, Yvorel C, Massin M, Leblon T, Chabbi C, Cugney E, Benabou L, Aubry M, Chan C, Boufoula I, Barnaud C, Bothorel L, Duceau B, Sutter W, Waldmann V, Bonnet G, Cohen A, Pezel T; Critical Covid-19 France Investigators.

COVID-19 and pulmonary embolism: an unwanted alliance

Torbicki A.

Response: D-dimer triage for COVID-19

Li C, Zhai Z, Davidson BL.

Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad

Ahmed S, Zimba O, Gasparyan AY.

Thrombotic circuit complications during venovenous extracorporeal membrane oxygenation in COVID-19

Bemtgen X, Zotzmann V, Benk C, Rilinger J, Steiner K, Asmussen A, Bode C, Wengenmayer T, Maier S, Staudacher DL.

COVID-19, coagulopathy and venous thromboembolism: more questions than answers

Marietta M, Coluccio V, Luppi M.

Prevention of endothelial dysfunction and thrombotic events in COVID-19 patients with familial hypercholesterolemia

Vuorio A, Kovanen PT.

Thromboinflammation in COVID-19 acute lung injury

Mitchell WB.

COVID-19-associated acute cerebral venous thrombosis: clinical, CT, MRI and EEG features

Roy-Gash F, Marine M, Jean-Michel D, Herve V, Raphael B, Nicolas E.

Letter to the Editor: D-dimer and presumptive diagnosis of COVID-19

Al-Najar E, Alrumaih F, Arab D, Drouin AS, Gosselin S, Sawa J.

Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole

DiNicolantonio JJ, Barroso-Aranda J.

RadioGraphics Update: Venous Thrombosis and Hypercoagulability in the Abdomen and Pelvis-Findings in COVID-19

Olson MC, Lubner MG, Menias CO, Mellnick VM, Gettle LM, Kim DH, Elsayes KM, Pickhardt PJ.

Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020

Ramacciotti E, Macedo AS, Biagioni RB, Caffaro RA, Lopes RD, Guerra JC, Orsi FA, Marques MA, Tafur AJ, Caprini JA, Nicolaides A, Carter CA, Filho CC, Fareed J.

Reducing the Risk of Venous Thrombosis During Self-Isolation and COVID-19 Pandemic for Patients With Cancer: Focus on Home Exercises Prescription

Demirci U, Ozdemir H, Demirbag-Kabayel D, Umit EG, Demir AM.

COVID-19 Coagulopathy: Considerations for Urologists

Jue JS, Alameddine M.

Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients

Zhang Y, Cao W, Jiang W, Xiao M, Li Y, Tang N, Liu Z, Yan X, Zhao Y, Li T, Zhu T.

Aortic thrombus in patients with severe COVID-19: review of three cases

de Carranza M, Salazar DE, Troya J, Alcázar R, Peña C, Aragón E, Domínguez M, Torres J, Muñoz-Rivas N.

Systematic review of the prognostic utility of D-dimer, disseminated intravascular coagulation, and anticoagulant therapy in COVID-19 critically ill patients

Moreno G, Carbonell R, Bodí M, Rodríguez A.

Fibrinolysis Resistance: A Potential Mechanism Underlying COVID-19 Coagulopathy

Weiss E, Roux O, Moyer JD, Paugam-Burtz C, Boudaoud L, Ajzenberg N, Faille D, de Raucourt E.

Correlation between cytokines and coagulation-related parameters in patients with coronavirus disease 2019 admitted to ICU

Zhang D, Zhou X, Yan S, Tian R, Su L, Ding X, Xiao M, Chen Y, Zhao H, Chen H, Zhang H, Li Z, Li Q, Xu Y, Yan X, Li Y, Zhang S.

Cold agglutinin disease and autoimmune hemolytic anemia with pulmonary embolism as a presentation of COVID-19 infection

Patil NR, Herc ES, Girgis M.

COVID-19 comorbidities, associated pro-coagulant extracellular vesicles and venous thromboembolisms: a possible link with ethnicity?

Inal J.

Thrombocytopaenia in pregnancy: the importance of differential diagnosis during the COVID-19 pandemic

Zitiello A, Grant GE, Ben Ali N, Feki A.

Rare Presentation of Pulmonary Embolism Amidst Coronavirus Disease 2019 Era: Utility of Multiorgan Ultrasonography

Ahmed T, Ahmed T, Kumar S, Lodhi SH, Akbik B.

Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis

Artru F, Alberio L, Moradpour D, Stalder G.

COVID-19-related thrombotic microangiopathy in a cirrhotic patient

Airoldi A, Perricone G, De Nicola S, Molisano C, Tarsia P, Belli LS.

Severe refractory thrombocytopenia in a woman positive for coronavirus disease 2019 with lupus and antiphospholipid syndrome

Hayden A, Vyas-Lahar A, Rella V, Rudinskaya A.

Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines

Fontana P, Casini A, Robert-Ebadi H, Glauser F, Righini M, Blondon M.

Dynamics of coagulopathy in patients with different COVID-19 severity

Kalinskaya A, Dukhin O, Molodtsov I, Maltseva A, Sokorev D, Elizarova A, Sapozhnikova O, Glebova K, Stonogina D, Shakhidzhanov S, Nikonov E, Mazus A, Spiridonov I, Ataullakhanov F, Margolis L, Shpektor A, Vasilieva E.

Circulating Markers of Angiogenesis and Endotheliopathy in COVID-19

Meizlish M, Pine A, Goshua G, Chang CH, Zhang H, Bishai J, Bahel P, Patel A, Gbyli R, Kwan J, Price C, Dela Cruz C, Halene S, van Dijk D, Hwa J, Lee AI, Chun HJ.

Possible formation of pulmonary microthrombi in the early puerperium of pregnant women critically ill with COVID-19: Two case reports

Tutiya CT, Siaulys MM, Kondo MM, Miglioli-Galv√£o L, C A Galv√£o E, Pinheiro CC, Torloni MR, de Mello FB.

Haematological manifestations, mechanisms of thrombosis and anti-coagulation in COVID-19 disease: A review

Kasinathan G, Sathar J.

NSAIDs may increase the risk of thrombosis and acute renal failure in patients with COVID-19 infection

Cumhur Cure M, Kucuk A, Cure E.

Atherosclerosis as Pathogenetic Substrate for Sars-Cov2 Cytokine Storm

Vinciguerra M, Romiti S, Fattouch K, De Bellis A, Greco E.

Mortality and the use of Antithrombotic Therapies among Nursing Home Residents with COVID-19

Brouns SH, Brüggemann R, Linkens A, Magdelijns FJ, Joosten H, Heijnen R, Ten Cate-Hoek AJ, Schols J, Ten Cate H, Spaetgens B.

Incidence of Deep Vein Thrombosis among non-ICU Patients Hospitalized for COVID-19 Despite Pharmacological Thromboprophylaxis

Santoliquido A, Porfidia A, Nesci A, De Matteis G, Marrone G, Porceddu E, Cammà G, Giarretta I, Fantoni M, Landi F, Gasbarrini A, Pola R; GEMELLI AGAINST COVID-19 Group.

Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?

Paar V, Wernly B, Zhou Z, Motloch LJ, Hoppe UC, Egle A, Lichtenauer M.

JAK inhibitors in COVID-19: need for vigilance regarding increased inherent thrombotic risk

Mehta P, Ciurtin C, Scully M, Levi M, Chambers RC.

[Thrombosis and COVID-19: Key primary care in the interdisciplinary approach]

Piera Carbonell A, García Lerín A, García Vallejo O, Frías Vargas M, Cabrera Ferriols MA.

Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection

Labò N, Ohnuki H, Tosato G.

Acute pulmonary embolism in COVID-19 disease

Kalemci S, Sarıhan A, Zeybek A, Kargi AB.

Practical considerations in prevention and treatment of venous thromboembolism in hospitalized patients with COVID-19

Smith K, Krajewski KC, Krajewski MP.

Comparison of Venous Thromboembolism Risks Between COVID-19 Pneumonia and Community-Acquired Pneumonia Patients

Mei F, Fan J, Yuan J, Liang Z, Wang K, Sun J, Guan W, Huang M, Li Y, Zhang WW.

A possible benefit from therapeutic anticoagulation in COVID-19: the Dolo hospital experience in Veneto, Italy

Secco E, Pasqualetto MC, Bombardini T, Picano E, Rigo F.

Thrombotic microangiopathy, DIC-syndrome and COVID-19: link with pregnancy prothrombotic state

Makatsariya AD, Slukhanchuk EV, Bitsadze VO, Khizroeva JKH, Tretyakova MV, Tsibizova VI, Elalamy I, Gris JC, Grandone E, Makatsariya NA, Mashkova T.

COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?

Mondal R, Lahiri D, Deb S, Bandyopadhyay D, Shome G, Sarkar S, Paria SR, Thakurta TG, Singla P, Biswas SC.

Heterogeneity in reporting venous thromboembolic phenotypes in COVID-19: Methodological issues and clinical implications

Kollias A, Kyriakoulis KG, Stergiou GS, Syrigos K.

Anticoagulation clinic drive-up service during COVID-19 pandemic in Qatar

Alhmoud E, Abdelsamad O, Soaly E, Enany RE, Elewa H.

Demystifying pulmonary vascular complications in severe coronavirus disease-19 pneumonia (COVID-19) in the light of clinico-radiologic-pathologic correlation

Parry AH, Wani AH, Yaseen M, Dar MI.

Potential underlying mechanisms of cerebral venous thrombosis associated with COVID-19

Speeckaert MM, Speeckaert R, Delanghe JR.

Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19

Ye W, Chen G, Li X, Lan X, Ji C, Hou M, Zhang D, Zeng G, Wang Y, Xu C, Lu W, Cui R, Cai Y, Huang H, Yang L.

Endothelial cells orchestrate COVID-19 coagulopathy

O'Sullivan JM, Gonagle DM, Ward SE, Preston RJS, O'Donnell JS.

Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study

Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, Baluha A, Bar N, Bona RD, Burns AJ, Dela Cruz CS, Dumont A, Halene S, Hwa J, Koff J, Menninger H, Neparidze N, Price C, Siner JM, Tormey C, Rinder HM, Chun HJ, Lee AI.

COVID-19 and venous thromboembolism: current insights and prophylactic strategies

Ambrosino P, Di Minno A, Maniscalco M, Di Minno MND.

Specific coagulation markers may provide more therapeutic targets in COVID-19 patients receiving prophylactic anticoagulant

Tang N, Bai H, Xiong D, Sun Z.

Antiphospholipid antibodies in patients with COVID-19: a relevant observation?

Devreese KMJ, Linskens EA, Benoit D, Peperstraete H.

COVID-19 May Predispose to Thrombosis by Affecting Both Vascular Endothelium and Platelets

Cure E, Cure MC.

Challenges for Management of Immune Thrombocytopenia during COVID-19 Pandemic

Sahu KK, Siddiqui AD, Rezaei N, Cerny J.

What Do We Really Know About Pulmonary Thrombosis in COVID-19 Infection?

Raptis CA, Hammer MM, Henry TS, Hope MD, Schiebler ML, van Beek EJR.

Detection of Pulmonary Embolism in Returning Travelers with Hypoxemic Pneumonia due to COVID-19 in Reunion Island

Larsen K, Coolen-Allou N, Masse L, Angelino A, Allyn J, Bruneau L, Maillot A, Lagrange-Xelot M, Vitry T, André M, Travers JY, Foch E, Allou N.

Rate of venous thromboembolism in a prospective all-comers cohort with COVID-19

Rieder M, Goller I, Jeserich M, Baldus N, Pollmeier L, Wirth L, Supady A, Bode C, Busch HJ, Schmid B, Duerschmied D, Gauchel N, Lother A.

Successful use of tPA for thrombolysis in COVID related ARDS: a case series

Goyal A, Saigal S, Niwariya Y, Sharma J, Singh P.

A Case of COVID-19 Infection With Delayed Thromboembolic Complication on Warfarin

Garg A, Goyal S, Patel P.

Intraluminal Carotid Artery Thrombus in COVID-19: Another Danger of Cytokine Storm?

Mohamud AY, Griffith B, Rehman M, Miller D, Chebl A, Patel SC, Howell B, Kole M, Marin H.

Acute Common Carotid Artery Bifurcation Thrombus: An Emerging Pattern of Acute Strokes in Patients with COVID-19?

Gulko E, Gomes W, Ali S, Al-Mufti F, Mehta H.

Dramatic presentation of acquired TTP associated with COVID-19

Capecchi M, Mocellin C, Abbruzzese C, Mancini I, Prati D, Peyvandi F.

Mesenchymal stem cells in the fight against viruses: Face to face with the invisible enemy

Sleem A, Saleh F.

C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis

Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B.

Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease

Chan KH, Slim J, Shaaban HS.

Acral purpuric lesions associated with coagulation disorders during the COVID-19 pandemic

García-Gil MF, Monte Serrano J, García García M, Barra Borao V, Matovelle Ochoa C, Ramirez-Lluch M, Ara-Martín M.

How to build the plane while flying: VTE/PE Thromboprophylaxis Clinical Guidelines for COVID-19 Patients

Costa A, Weinstein ES, Sahoo DR, Thompson SC, Faccincani R, Ragazzoni L.

Perspective: Vitamin D deficiency and COVID-19 severity - plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2, and thrombosis (R1)

Rhodes JM, Subramanian S, Laird E, Griffin G, Kenny RA.

Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis

Mestre-Gómez B, Lorente-Ramos RM, Rogado J, Franco-Moreno A, Obispo B, Salazar-Chiriboga D, Saez-Vaquero T, Torres-Macho J, Abad-Motos A, Cortina-Camarero C, Such-Diaz A, Ruiz-Velasco E, Churruca-Sarasqueta J, Muñoz-Rivas N; Infanta Leonor Thrombosis Research Group.

Severe immune thrombocytopenic purpura in critical COVID-19

Lévesque V, Millaire É, Corsilli D, Rioux-Massé B, Carrier FM.

Massive Pulmonary Thromboembolism in Patients with COVID-19; Report of Three Cases

Pishgahi M, Ansari Aval Z, Hajimoradi B, Bozorgmehr R, Safari S, Yousefifard M.

Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicity

Jansen AJG, Spaan T, Low HZ, Di Iorio D, van den Brand J, Tieke M, Barendrecht A, Rohn K, van Amerongen G, Stittelaar K, Baumgärtner W, Osterhaus A, Kuiken T, Boons GJ, Huskens J, Boes M, Maas C, van der Vries E.

RE: RE: COVID-19 Coagulopathy: Considerations for Urologists

Jue JS, Alameddine M.

coagulation profile in severe COVID-19 patients: what do we know so far?

Savioli F, Rocha LL.

COVID-19: a collision of complement, coagulation and inflammatory pathways

Chauhan AJ, Wiffen LJ, Brown TP.

Lupus anticoagulant is frequent in patients with Covid-19: Response to Reply

Harzallah I, Debliquis A, Drénou B.

Response to 'the association between D-dimer in COVID-19 patients and mortality remains beset of uncertainties'

Zhang L, Yan X, Gong Y, Zhang Z.

DVT incidence and risk factors in critically ill patients with COVID-19

Chen S, Zhang D, Zheng T, Yu Y, Jiang J.

Large intracardiac thrombus in a COVID-19 patient treated with prolonged extracorporeal membrane oxygenation implantation

Hu D, Liu K, Li B, Hu Z.

COVID-19 as triggering co-factor for cortical cerebral venous thrombosis?

Coline B, Thierry D, Amandine K, Nathalie M, Pierre RM.

Hypercoagulability in COVID-19: Identification of Arterial and Venous Thromboembolism in the Abdomen, Pelvis, and Lower Extremities

Dane B, Smereka P, Wain R, Kim D, Katz DS.

Manifestations of blood coagulation and its relation to clinical outcomes in severe COVID-19 patients: Retrospective analysis

Zhang Y, He L, Chen H, Lu S, Xiong Y, Liu J, Zheng Y, Wang S, Liu L.

COVID-19 and simultaneous thrombosis of two coronary arteries

Rey JR, Jiménez Valero S, Poveda Pinedo D, Merino JL, López-Sendón JL, Caro-Codón J.

SEDAR-SEMICYUC consensus recommendations on the management of haemostasis disorders in severely ill patients with COVID-19 infection

Llau JV, Ferrandis R, Sierra P, Hidalgo F, Cassinello C, Gómez-Luque A, Quintana M, Amezaga R, Gero M, Serrano A, Marcos P.

COVID-19 Pneumonia Hospitalizations Followed by Re-presentation for Presumed Thrombotic Event

Brosnahan SB, Bhatt A, Berger JS, Yuriditsky E, Iturrate E, Amoroso NE.

Pulmonary embolism in acute medicine: a case-based review incorporating latest guidelines in the COVID-19 era

Stevenson A, Davis S, Murch N.

Severe COVID-19 Pneumonia and Very Late Stent Thrombosis: a Trigger or Innocent Bystander?

Galeazzi GL, Loffi M, Di Tano G, Danzi GB.

The protective rather than prothrombotic fibrinogen in COVID-19 and other inflammatory states

Thachil J.

Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review)

Cavalli E, Bramanti A, Ciurleo R, Tchorbanov AI, Giordano A, Fagone P, Belizna C, Bramanti P, Shoenfeld Y, Nicoletti F.

Prevalence, specificity, and clinical association of anti-phospholipid antibodies in COVID-19 patients: are the antibodies really guilty?

Borghi MO, Beltagy A, Garrafa E, Curreli D, Cecchini G, Bodio C, Grossi C, Blengino S, Tincani A, Franceschini F, Andreoli L, Lazzaroni MG, Piantoni S, Masneri S, Crisafulli F, Brugnoni D, Muiesan ML, Salvetti M, Parati G, Torresani E, Mahler M, Heilbron F, Pregnolato F, Pengo M, Tedesco F, Pozzi N, Meroni PL.

Prothrombotic antiphospholipid antibodies in COVID-19

Zuo Y, Estes SK, Gandhi AA, Yalavarthi S, Ali RA, Shi H, Sule G, Gockman K, Madison JA, Zuo M, Woodard W, Lezak SP, Lugogo NL, Kanthi Y, Knight JS.

Management of ST-Elevation Myocardial Infarction in the COVID-19 Era: The Role of Thrombosis and Anticoagulation Strategy

Al-Sadawi M, Mohiuddin A, Hossain N, Shaikh S, Feit A, Ramalanjaona B, Salifu MO, McFarlane SI.

A mechanistic analysis placental intravascular thrombus formation in COVID-19 patients

Pulmonary embolism and acro-ischemia in a lung cancer patient with COVID-19

González Del Portillo E, Pérez-Romasanta LA.

Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol

Marietta M, Vandelli P, Mighali P, Vicini R, Coluccio V, D'Amico R; COVID-19 HD Study Group.

The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications

McFadyen JD, Stevens H, Peter K.

Occurrence of Acute Pulmonary Embolism in COVID-19 - A Case Series

Bavaro DF, Poliseno M, Scardapane A, Belati A, De Gennaro N, Stabile Ianora AA, Angarano G, Saracino A.

[Acral ischaemia with multiple microthromboses and imminent gangrene in a 73-year-old woman with COVID-19]

Andersen MB, Lund ML, Jacobsn S, Kümle T, Simonsen S, Ravn P.

COVID-19-associated Hemophagocytic Lymphohistiocytosis and Coagulopathy: Targeting the Duumvirate

Bhattacharjee S, Banerjee M, Pal R.

Coagulation Panel in Patients with SARS-CoV2 Infection (COVID-19)

Guevara-Noriega KA, Lucar-Lopez GA, Nuñez G, Rivera-Aguasvivas L, Chauhan I.

Platelets and Immunity: Going Viral

Koupenova M, Freedman JE.

Oral erosions and petechiae during SARS-CoV-2 infection

Ciccarese G, Drago F, Boatti M, Porro A, Muzic SI, Parodi A.

Systemic inflammatory response and thrombosis due to alterations in the gut microbiota in COVID-19

Mönkemüller K, Fry LC, Rickes S.

COVID-19. Immunothrombosis and the gastrointestinal tract

A Cienfuegos J, Almeida Vargas A, S√°nchez Justicia C.

Reperfusion treatment for high-risk pulmonary embolism associated with COVID-19

Barco S, Münger M, Sebastian T, Kucher N.

ADL-dependency, D-Dimers, LDH and absence of anticoagulation are independently associated with one-month mortality in older inpatients with Covid-19

Bousquet G, Falgarone G, Deutsch D, Derolez S, Lopez-Sublet M, Goudot FX, Amari K, Uzunhan Y, Bouchaud O, Pamoukdjian F.

Reply to LTE: COVID-19 and pulmonary embolism: diagnostic imaging trends

Zuckier LS, Moadel RM, Haramati LB, Freeman LM.

[Understanding and prevention of D-dimer elevation in coronavirus disease 2019 in traditional Chinese medicine]

Wang Q, Wang C, Mei J, He L, Li J, Liu S, Chen F.

[Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019]

Xu Y, Qian Y, Gu Q, Tang J.

COVID-19 coagulopathy vs disseminated intravascular coagulation

Levi M.

MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy

Moll G, Drzeniek N, Kamhieh-Milz J, Geissler S, Volk HD, Reinke P.

Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?

Berthelot JM (MD-HDR), Drouet L (MD-PhD), Lioté F (MD-PhD).

Correction to: Heparin resistance in COVID‑19 patients in the intensive care unit

White D, MacDonald S, Bull T, Hayman M, de Monteverde-Robb D, Sapsford D, Lavinio A, Varley J, Johnston A, Besser M, Thomas W.

Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy

Saini KS, Lanza C, Romano M, de Azambuja E, Cortes J, de Las Heras B, de Castro J, Lamba Saini M, Loibl S, Curigliano G, Twelves C, Leone M, Patnaik MM.

Proposal of the French Society of Vascular Medicine for the prevention, diagnosis and treatment of venous thromboembolic disease in outpatients with COVID-19

Khider L, Soudet S, Laneelle D, Boge G, Bura-Rivière A, Constans J, Dadon M, Desmurs-Clavel H, Diard A, Elias A, Emmerich J, Galanaud JP, Giordana P, Gracia S, Hamade A, Jurus C, Le Hello C, Long A, Michon-Pasturel U, Mirault T, Miserey G, Perez-Martin A, Pernod G, Quere I, Sprynger M, Stephan D, Wahl D, Zuily S, Mahe G, Sevestre MA; French Society of Vascular Medicine (SFMV).

Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review

Fletcher-Sandersjöö A, Bellander BM.

COVID-19: review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking

Magro G.

Current Perspectives of Anticoagulation in Patients with COVID-19

Gavioli EM, Sikorska G, Man A, Rana J, Vider E.

COVID-19 and the endothelium

Jung F, Krüger-Genge A, Franke RP, Hufert F, Küpper JH.

Prothrombotic state induced by COVID-19 infection as trigger for stroke in young patients: A dangerous association

Cavallieri F, Marti A, Fasano A, Salda AD, Ghirarduzzi A, Moratti C, Bonacini L, Ghadirpour R, Pascarella R, Valzania F, Zedde M.

Guidance on diagnosis, prevention and treatment of thromboembolic complications in COVID-19: a position paper of the Brazilian Society of Thrombosis and Hemostasis and the Thrombosis and Hemostasis Committee of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy

Orsi FA, De Paula EV, Santos FO, Teruchkin MM, Campêlo DHC, Mello TT, Chindamo MC, Macedo AVS, Rocha AT, Ramacciotti E, Nascimento ACK, Annichino-Bizzacchi J, Lourenco DM, Guerra JCC, Rezende SM, Cavalheiro Filho C.

The thromboembolic risk in covid-19 women under hormonal treatment group

Ramírez I, De la Viuda E, Baquedano L, Coronado P, Llaneza P, Mendoza N, Otero B, Sánchez S, Cancelo MJ, Páramo JA, Cano A.

Protective role of chronic treatment with direct oral anticoagulants in elderly patients affected by interstitial pneumonia in COVID-19 era

Rossi R, Coppi F, Talarico M, Boriani G.

Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring

Susen S, Tacquard CA, Godon A, Mansour A, Garrigue D, Nguyen P, Godier A, Testa S, Levy JH, Albaladejo P, Gruel Y; GIHP and GFHT.

Rationale for targeting Complement in COVID-19

Polycarpou A, Howard M, Farrar CA, Greenlaw R, Fanelli G, Wallis R, Klavinskis LS, Sacks S.

COVID-19-associated coagulopathy: An exploration of mechanisms

Colling ME, Kanthi Y.

Curative anticoagulation prevents endothelial lesion in COVID-19 patients

Khider L, Gendron N, Goudot G, Chocron R, Hauw-Berlemont C, Cheng C, Rivet N, Pere H, Roffe A, Clerc S, Lebeaux D, Debuc B, Veyer D, Rance B, Gaussem P, Bertil S, Badoual C, Juvin P, Planquette B, Messas E, Sanchez O, Hulot JS, Diehl JL, Mirault T, Smadja DM.

COVID-19 anticoagulation recommendations in children

Loi M, Branchford B, Kim J, Self C, Nuss R.

Coagulopathy in COVID-19

Iba T, Levy JH, Levi M, Thachil J.

Catastrophic acute bilateral lower limbs necrosis associated with COVID-19 as a likely consequence of both vasculitis and coagulopathy

Del Giudice P, Boudoumi D, Le Guen B, Reverte M, Gutnecht J, Lacour JP, Kraemer JP, Motard A, Roa M.

Thrombocytopenia is independently associated with poor outcome in patients hospitalized for COVID-19

Maquet J, Lafaurie M, Sommet A, Moulis G; Covid-Clinic-Toul investigators group, Alvarez M, Amar J, Attal M, Balardy L, Balen F, Beyne-Rauzy O, Bouali O, Bounes F, Bureau C, Buscail L, Calviere L, Charpentier S, Chollet F, Claudet I, Constantin A, Debard A, Delavigne K, Delobel P, Delrieu J, Didier A, Faruch M, Fourcade O, Georges B, Grunenwald E, Guyonnet S, Hanaire H, Hein C, Kamar N, Lairez O, Mansat P, Martin-Blondel G, Minville V, Pariente J, Paul C, Payoux P, Pugnet G, Piel-Julian ML, Rech

Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)?

Dorgalaleh A, Dabbagh A, Tabibian S, Baghaeipour MR, Jazebi M, Bahraini M, Fazeli S, Rad F, Baghaeipour N.

The Role of Anticoagulation in COVID-19-Induced Hypercoagulability

Rico-Mesa JS, Rosas D, Ahmadian-Tehrani A, White A, Anderson AS, Chilton R.

Antithrombotic Therapies in COVID-19 Disease: a Systematic Review

Maldonado E, Tao D, Mackey K.

Cerebral involvement in COVID-19 is associated with metabolic and coagulation derangements: an EEG study

Cecchetti G, Vabanesi M, Chieffo R, Fanelli G, Minicucci F, Agosta F, Tresoldi M, Zangrillo A, Filippi M.

Ventilation/perfusion SPECT/CT findings in different lung lesions associated with COVID-19: a case series

Cobes N, Guernou M, Lussato D, Queneau M, Songy B, Bonardel G, Grellier JF.

The renin-angiotensin system: An integrated view of lung disease and coagulopathy in COVID-19 and therapeutic implications

Diamond B.

[Coagulopathy in COVID-19: pathophysiology]

Pierini S, Incampo E, Bokor D, Dadone V, Ornaghi M, Zanini F, Gentile F, Mancarella S.

Thrombosis and COVID-19 pneumonia: the clot thickens!

Price LC, McCabe C, Garfield B, Wort SJ.

Cerebral Venous Thrombosis Associated with COVID-19

Cavalcanti DD, Raz E, Shapiro M, Dehkharghani S, Yaghi S, Lillemoe K, Nossek E, Torres J, Jain R, Riina HA, Radmanesh A, Nelson PK.

Atypical Deep Cerebral Vein Thrombosis with Hemorrhagic Venous Infarction in a Patient Positive for COVID-19

Chougar L, Mathon B, Weiss N, Degos V, Shor N.

Cautious Interpretation of Antiphospholipid Antibodies in COVID-19

Mehta S, Bhandari S, Mehta S.

The unique characteristics of COVID-19 coagulopathy

Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M.

A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors

Nicolson PL, Welsh JD, Chauhan A, Thomas MR, Kahn ML, Watson SP.

NOVEL INSIGHTS ON THE PULMONARY VASCULAR CONSEQUENCES OF COVID-19

Potus F, Mai V, Lebret M, Malenfant S, Breton-Gagnon E, Lajoie AC, Boucherat O, Bonnet S, Provencher S.

Coagulation dysfunction: A hallmark in COVID-19

Fei Y, Tang N, Liu H, Cao W.

Pulmonary embolism and COVID-19. Persistent pulmonary hypertension?

Cruz-Utrilla A, Calderón-Flores M, Escribano-Subias MP.

Anticoagulation Options for Coronavirus Disease 2019 (COVID-19)-Induced Coagulopathy

Turshudzhyan A.

The thromboembolism in COVID-19: the unsolved problem

Casale M, Dattilo G, Imbalzano E, Gigliotti De Fazio M, Morabito C, Mezzetti M, Busacca P, Signorelli SS, Brunetti ND, Correale M.

Endotheliitis and Endothelial Dysfunction in Patients with COVID-19: Its Role in Thrombosis and Adverse Outcomes

Mosleh W, Chen K, Pfau SE, Vashist A.

COVID-19 hypothesis: Activated protein C for therapy of virus-induced pathologic thromboinflammation

Griffin JH, Lyden P.

The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection

Pons S, Fodil S, Azoulay E, Zafrani L.

Acute cor pulmonale from saddle pulmonary embolism in a patient with previous Covid-19 - should we prolong prophylactic anticoagulation?

Ali S, Pappachan JM, Mathew S.

Fibrinolysis and COVID-19: a plasmin paradox

Medcalf RL, Keragala CB, Myles PS.

Emergence of institutional antithrombotic protocols for coronavirus 2019

Cohoon KP, Mahé G, Tafur AJ, Spyropoulos AC.

COVID-19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance

Cannegieter SC, Klok FA.

Thrombus in Transit and Impending Pulmonary Embolism Detected on POCUS in a Patient with COVID-19 Pneumonia

Kariyanna PT, Hossain NA, Jayarangaiah A, Hossain NA, Uppin V, Hegde S, Capric V, Salifu MO, McFarlane SI.

COVID-19-associated pulmonary and cerebral thromboembolic disease

Gill I, Chan S, Fitzpatrick D.

Factor VIII and Functional Protein C Activity in Critically Ill Patients With Coronavirus Disease 2019: A Case Series

Tabatabai A, Rabin J, Menaker J, Madathil R, Galvagno S, Menne A, Chow JH, Grazioli A, Herr D, Tanaka K, Scalea T, Mazzeffi M.

PPIs and Beyond: A Framework for Managing Anticoagulation-Related Gastrointestinal Bleeding in the Era of COVID-19

Patel P, Sengupta N.

Rethinking COVID-19 'pneumonia' - is this primarily a vaso-occlusive disease, and can early anticoagulation save the ventilator famine?

Low TT, Cherian R, Lim SL, Chandra B, Tung ML, Kumar SK, Lye P, Chin Xin Yi A, Teo L, Tay EL.

Mechanisms involved in the development of thrombocytopenia in patients with COVID-19

Zhang Y, Zeng X, Jiao Y, Li Z, Liu Q, Yang M, Ye J.

Spontaneous coronavirus disease 2019 (COVID-19)-associated luminal aortic thrombus

Mullan C, Powierza C, Miller PE, Geirsson A, Vallabhajosyula P, Assi R.

COVID-19 and thrombotic complications: Pulmonary thrombosis rather than embolism?

Gabrielli M, Lamendola P, Esperide A, Valletta F, Franceschi F.

Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidase

DiNicolantonio JJ, McCarty M.

Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: A different phenotype of thrombotic disease?

van Dam LF, Kroft LJM, van der Wal LI, Cannegieter SC, Eikenboom J, de Jonge E, Huisman MV, Klok FA.

Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?

Mohamed-Hussein AAR, Aly KME, Ibrahim MAA.

New (re)Purpose for an old drug: purinergic receptor blockade may extinguish the COVID-19 thrombo-inflammatory firestorm

Kanthi Y, Knight JS, Zuo Y, Pinsky DJ.

Pulmonary Artery Embolism in COVID-19 Despite Thrombosis Prophylaxis

Geerdes-Fenge HF, Reisinger EC, Arndt H.

Pulmonary Embolism in Covid-19. Coagulation Parameters, Close Monitoring to Prevent?

Annunziata A, Imitazione P, Polistina GE, Lanza M, Coppola A, Fiorentino G.

High Frequency of Antiphospholipid Antibodies in Critically-ill COVID-19 Patients: a Link with Hypercoagulability?

Pineton de Chambrun M, Frere C, Miyara M, Amoura Z, Martin-Toutain I, Mathian A, Hekimian G, Combes A.

Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment

Aryal MR, Gosain R, Donato A, Pathak R, Bhatt VR, Katel A, Kouides P.

Systematic Screening for Venous Thromboembolic Events in COVID-19 Pneumonia

Grandmaison G, Andrey A, Périard D, Engelberger RP, Carrel G, Doll S, Dexpert JB, Krieger C, Ksouri H, Hayoz D, Sridharan G.

Thromboembolic risks in patients with COVID-19: major concern to consider in our management

Temgoua MN, Kuaté LM, Ngatchou W, Sibetcheu A, Toupendi ZN, Belobo G, Ossa A, Kingue S.

COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?

Ferrandis R, Llau JV, Quintana M, Sierra P, Hidalgo F, Cassinello C, Gómez-Luque A.

Pulmonary embolism: A complication of COVID 19 infection

Akel T, Qaqa F, Abuarqoub A, Shamoon F.

Response to 'all these D-dimers in COVID-19'

Zhang L.

Thrombotic microangiopathy in a patient with COVID-19

Jhaveri KD, Meir LR, Flores Chang BS, Parikh R, Wanchoo R, Barilla-LaBarca ML, Bijol V, Hajizadeh N.

Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis

Yu B, Li X, Chen J, Ouyang M, Zhang H, Zhao X, Tang L, Luo Q, Xu M, Yang L, Huang G, Liu X, Tang J.

Pulmonary embolism: yet another cause of hypoxaemic respiratory failure in COVID-19

Nieri D, Lenzini G, Canari Venturi B, Celi A.

D-dimer and C-reactive Protein Blood Levels Over Time Used to Predict Pulmonary Embolism in Two COVID-19 Patients

Becher Y, Goldman L, Schacham N, Gringauz I, Justo D.

Thrombocytopenia in the Course of COVID-19 Infection

Lorenzo-Villalba N, Zulfiqar AA, Auburtin M, Schuhmacher MH, Meyer A, Maouche Y, Keller O, Andres E.

COVID-19 and Pulmonary Embolism: Not a Coincidence

Tamburello A, Bruno G, Marando M.

Non-Overt Coagulopathy in Non-ICU Patients with Mild to Moderate COVID-19 Pneumonia

Mazzaccaro D, Giacomazzi F, Giannetta M, Varriale A, Scaramuzzo R, Modafferi A, Malacrida G, Righini P, Marrocco-Trischitta MM, Nano G.

Viral infections and atherothrombosis: Another caution in the wake of COVID-19?

Pereira MP, Lima EG, Serrano Junior CV.

COVID-19 and pulmonary embolism: Do not forget the association!

Mariano RZ, Ramos MC, Reis F.

Incidence and consequences of systemic arterial thrombotic events in COVID-19 patients

Cantador E, Núñez A, Sobrino P, Espejo V, Fabia L, Vela L, de Benito L, Botas J.

Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19

Bautista-Vargas M, Bonilla-Abadía F, Cañas CA.

Acute pulmonary embolism in non-hospitalized COVID-19 patients referred to CTPA by emergency department

Gervaise A, Bouzad C, Peroux E, Helissey C.

COVID-19 and telemedicine in hemophilia in a patient with severe hemophilia A and orthopedic surgery

Álvarez-Román MT, De la Corte-Rodríguez H, Rodríguez-Merchán EC, Martín-Salces M, Rivas-Pollmar MI, Butta NV, García-Barcenilla S, Acuña P, Cebanu T, González E, Monzón-Manzano E, Jiménez-Yuste V.

Severe bleeding in a patient with Factor XIII deficiency and COVID-19

Quintavalle G, Coppola A, Ruggieri A, Franca Rivolta G, Fronti E, Giangregorio F, Michieletti E, Tagliaferri A.

Anticoagulation with Argatroban in patients with acute antithrombin deficiency in severe COVID -19

Arachchillage DJ, Remmington C, Rosenberg A, Xu T, Passariello M, Hall D, Laffan AM, Patel BV.

Guidance for anticoagulation management in venous thromboembolism during the coronavirus disease 2019 (COVID-19) pandemic in Poland: an expert opinion of the Section on Pulmonary Circulation of the Polish Cardiac Society

Kosior DA, Undas A, Kopeć G, Hryniewiecki T, Torbicki A, Mularek-Kubzdela T, Windyga J, Pruszczyk P.

[Forh√∏jet D-dimer og karakteristiske billeddiagnostiske fund hos patient med COVID-19]

Lynggaard SE, Nygaard L, Overgaard EK.

Ovarian vein thrombosis after coronavirus disease (COVID-19) infection in a pregnant woman: case report

Mohammadi S, Abouzaripour M, Hesam Shariati N, Hesam Shariati MB.

Low-Intensity Monitoring After Stroke Thrombolysis During the COVID-19 Pandemic

Faigle R, Johnson B, Summers D, Khatri P, Anderson CS, Urrutia VC; OPTIMISTmain Steering Committee.

Managing anticoagulation in the COVID-19 era between lockdown and reopening phases

Poli D, Tosetto A, Palareti G, Barcellona D, Ciampa A, Grandone E, Manotti C, Moia M, Squizzato A, Toschi V, Testa S; On the behalf of Italian Federation of Anticoagulation Clinics (FCSA).

COVID-19 and fat embolism: a hypothesis to explain the severe clinical outcome in people with obesity

Cinti S, Graciotti L, Giordano A, Valerio A, Nisoli E.

COVID-19 quarantine and acute pulmonary embolism

Vannini L, Llanos Gómez JM, Quijada-Fumero A, Fernández Pérez AB, Hernández Afonso JS.

Abdominal pain in a patient with COVID-19 infection: A case of multiple thromboemboli

Mahan K, Kabrhel C, Goldsmith AJ.

COVID-19 Critical Illness Pathophysiology Driven by Diffuse Pulmonary Thrombi and Pulmonary Endothelial Dysfunction Responsive to Thrombolysis

Poor HD, Ventetuolo CE, Tolbert T, Chun G, Serrao G, Zeidman A, Dangayach NS, Olin J, Kohli-Seth R, Powell CA.

Neutrophil extracellular traps and thrombosis in COVID-19

Zuo Y, Zuo M, Yalavarthi S, Gockman K, Madison JA, Shi H, Woodard W, Lezak SP, Lugogo NL, Knight JS, Kanthi Y.

Thromboprophylaxis in COVID-19: Anti-FXa - The Missing Factor?

Dutt T, Simcox D, Downey C, McLenaghan D, King C, Gautam M, Lane S, Burhan H.

Coronavirus Disease 2019 (COVID-19) Infection Associated With Antiphospholipid Antibodies and Four-Extremity Deep Vein thrombosis in a Previously Healthy Female

Sung J, Anjum S.

Pharmacists reinventing their roles to effectively respond to COVID-19: a global report from the international pharmacists for anticoagulation care taskforce (iPACT)

Alves da Costa F, Lee V, Leite SN, Murillo MD, Menge T, Antoniou S.

Hypoalbuminemia, Coagulopathy and Vascular Disease in Covid-19

Violi F, Ceccarelli G, Cangemi R, Alessandri F, d'Ettorre G, Oliva A, Pastori D, Loffredo L, Pignatelli P, Ruberto F, Venditti M, Pugliese F, Mastroianni CM.

COVID-19 critical illness pathophysiology driven by diffuse pulmonary thrombi and pulmonary endothelial dysfunction responsive to thrombolysis

Poor HD, Ventetuolo CE, Tolbert T, Chun G, Serrao G, Zeidman A, Dangayach NS, Olin J, Kohli-Seth R, Powell CA.

Predicted value of coagulation function for prognosis and admission time to negative RT-PCR detection in non-critical COVID-19 patients

Meng Z, Ren D, Liu Y, Lu X, Xiong W, Jin X.

Pulmonary embolism and COVID-19: A paradigm change

Franco-Moreno A, Muñoz-Rivas N, Mestre-Gómez B, Torres-Macho J.

D-dimer triage for COVID-19

Li C, Hu B, Zhang Z, Qin W, Zhu Z, Zhai Z, Davidson BL, Wang C.

Viral Infections and Their Relationship with Catastrophic Antiphospholipid Syndrome: A Possible Pathogenic Mechanism of Severe COVID-19 Thrombotic Complications

Mendoza-Pinto C, Escárcega RO, García-Carrasco M, Bailey DJO, Gálvez-Romero JL, Cervera R.

Hyperacute multi-organ thromboembolic storm in COVID-19: a case report

Chibane S, Gibeau G, Poulin F, Tessier P, Goulet M, Carrier M, Lanthier S.

Could antiphospholipid antibodies contribute to coagulopathy in COVID-19?

Parodi A, Gasparini G, Cozzani E.

ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients

Escher R, Breakey N, Lämmle B.

Dysfunctional Coagulation in COVID-19: From Cell to Bedside

Wang J, Saguner AM, An J, Ning Y, Yan Y, Li G.

Diagnosis of venous and arterial thromboembolic events in COVID-19 virus-infected patients

Betoule A, Martinet C, Gasperini G, Muller P, Foucher S, Benner P, Renard A.

The burden of thrombotic complications in critically ill patients with COVID-19: charting the uncharted

Landi A, De Servi S.

[Increased risk of deep vein thrombosis in intensive care unit patients with CoViD-19 infections?-Preliminary data]

Zerwes S, Hernandez Cancino F, Liebetrau D, Gosslau Y, Warm T, Märkl B, Hyhlik-Dürr A.

Abrupt deterioration and pulmonary embolism in COVID-19: a case report

Motwani M.

Concomitant brain arterial and venous thrombosis in a COVID-19 patient

Malentacchi M, Gned D, Angelino V, Demichelis S, Perboni A, Veltri A, Bertolotto A, Capobianco M.

Prevention, diagnosis and treatment of venous thromboembolism in patients with COVID-19: CHEST Guideline and Expert Panel Report

Moores LK, Tritschler T, Brosnahan S, Carrier M, Collen JF, Doerschug K, Holley AB, Jimenez D, LeGal G, Rali P, Wells P.

Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA)

Linnemann B, Bauersachs R, Grebe M, Klamroth R, Müller O, Schellong S, Lichtenberg M.

Superficial thrombophlebitis in a patient with COVID 19: Heparin treatment after evaluation of D - Dimer: COVID 19 and Superficial thrombophlebitis

Demirbaş A, Elmas ÖF, Türsen Ü, Atasoy M, Lotti T.

Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy-a case report

Hu Z, Chen W, Liang W, Xu C, Sun W, Yi Y.

Arterial thrombotic complications in hospitalized patients with COVID-19

Rey JR, Caro-Codón J, Poveda Pineda D, Merino JL, Iniesta ÁM, López-Sendón JL; CARD-COVID investigators.

Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia

Ramírez I, De la Viuda E, Baquedano L, Coronado P, Llaneza P, Mendoza N, Otero B, Sánchez S, Cancelo MJ, Páramo JA, Cano A.

Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis

Langer F, Kluge S, Klamroth R, Oldenburg J.

Combination of thrombolytic and immunosuppressive therapy for coronavirus disease 2019: A case report

Papamichalis P, Papadogoulas A, Katsiafylloudis P, Skoura AL, Papamichalis M, Neou E, Papadopoulos D, Karagiannis S, Zafeiridis T, Babalis D, Komnos A.

The role of vascular surgeons in the treatment of COVID-19-associated pulmonary embolism

Patelis N, Bisdas T, Tsiachris D, Stefanadis CI.

Pulmonary embolism response teams in the challenging era of venous thromboembolism associated with COVID-19

Porres-Aguilar M, Ayala A, Mukherjee D, Tapson VF.

COVID-19 presenting with immune thrombocytopenia: a case report and review of the literature

Murt A, Eskazan AE, Yılmaz U, Ozkan T, Ar MC.

Pulmonary Artery Thrombectomy - A Life Saving Treatment in a Patient with Presumed COVID-19 complicated by a massive Pulmonary Embolus

Carlsson TL, Walton B, Collin G.

Letter: Thrombotic Neurovascular Disease in COVID-19 Patients

Sweid A, Hammoud B, Weinberg JH, Oneissi M, Raz E, Shapiro M, DePrince M, Tjoumakaris S, Gooch MR, Herial NA, Zarzour H, Romo V, Rosenwasser RH, Jabbour P.

The association between D-dimers in COVID-19 patients and mortality remains beset of uncertainties

Gris JC, Loubet P, Roger C, Cochery-Nouvellon E, Mauboussin JM, Muller L, Bouvier S, Laureillard D, Davide Barbar S, Mercier É, Lefrant JY, Sotto A.

COVID-19 Presented With Deep Vein Thrombosis: An Unusual Presenting

Davoodi L, Jafarpour H, Taghavi M, Razavi A.

COVID and Coagulation: Bleeding and Thrombotic Manifestations of SARS-CoV2 Infection

Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JC, Fogerty AE, Waheed A, Goodarzi K, Bendapudi P, Bornikova L, Gupta S, Leaf D, Kuter DJ, Rosovsky RP.

Right-to-left interatrial shunt in COVID-19 patients with pulmonary embolism

Fabre O, Rebet O, Hysi I.

Retiform purpura as a dermatological sign of covid-19 coagulopathy

Bosch-Amate X, Giavedoni P, Podlipnik S, Andreu-Febrer C, Sanz-Beltran J, Garcia-Herrera A, Alós L, Mascaró JM Jr.

COVID-19 and acute pulmonary embolism: what should be considered to indicate a computed tomography pulmonary angiography scan?

Moreira BL, Santana PRP, Zanetti G, Marchiori E.

COVID-19 and Hypercoagulable State: A New Therapeutic Perspective

Nascimento JHP, Gomes BFO, Carmo J√∫nior PRD, Petriz JLF, Rizk SI, Costa IBSDS, Lacerda MVG, Bacal F, Hajjar LA, Oliveira GMM.

COVID-19 pneumonia: a risk factor for pulmonary thromboembolism?

Jasinowodolinski D, Filisbino MM, Baldi BG.

Coagulation modifiers targeting SARS-CoV-2 main protease Mpro for COVID-19 treatment: an in silico approach

Biembengut ÍV, de Souza TACB.

Is there a rationale for heparin use among severe COVID-19 patients?

Savioli F.

Radiological approach to COVID-19 pneumonia: Attention should be paid to pulmonary embolism and radiation exposure

Ufuk F.

Thromboinflammatory response in SARS-CoV-2 sepsis

Maiese A, Passaro G, Matteis A, Fazio V, Raffaele R, Paolo MD.

Microthrombotic Complications of COVID-19 Are Likely Due to Embolism of Circulating Endothelial Derived Ultralarge Von Willebrand Factor (eULVWF) Decorated-Platelet Strings

Varatharajah N, Rajah S.

Blood clots and TAM receptor signalling in COVID-19 pathogenesis

Lemke G, Silverman GJ.

Severe pulmonary embolism in COVID-19 patients: a call for increased awareness

Hékimian G, Lebreton G, Bréchot N, Luyt CE, Schmidt M, Combes A.

Thrombotic and hemorrhagic events in critically ill COVID-19 patients: a French monocenter retrospective study

Fraissé M, Logre E, Pajot O, Mentec H, Plantefève G, Contou D.

COVID-19 Related Coagulopathy: A Distinct Entity?

Marchandot B, Sattler L, Jesel L, Matsushita K, Schini-Kerth V, Grunebaum L, Morel O.

Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom

Desborough MJR, Doyle AJ, Griffiths A, Retter A, Breen KA, Hunt BJ.

Thrombosis risk associated with COVID-19 infection. A scoping review

Al-Ani F, Chehade S, Lazo-Langner A.

Prevalence of Venous Thromboembolism in Critically Ill Patients with COVID-19

Hippensteel JA, Burnham EL, Jolley SE.

Re The source of elevated plasma D-dimer levels in COVID-19 infection

Hunt BJ, Levi M.

Elevated Cardiac Troponin I Is Associated with Poor Outcomes in COVID-19 Patients at an Academic Medical Center in Midwestern USA

Franks CE, Scott MG, Farnsworth CW.

Isolated severe thrombocytopenia in a patient with COVID-19: A case report

Sadr S, SeyedAlinaghi S, Ghiasvand F, Hassan Nezhad M, Javadian N, Hossienzade R, Jafari F.

High prevalence of deep vein thrombosis in mechanically ventilated COVID-19 patients

Voicu S, Bonnin P, Stépanian A, Chousterman BG, Le Gall A, Malissin I, Deye N, Siguret V, Mebazaa A, Mégarbane B.

Challenges in COVID-19: is pulmonary thromboembolism related to overall severity?

Bellieni A, Intini E, Taddei E, Baldi F, Larosa L, Murri R, Richeldi L, Bernabei R, Cauda R, Landi F, Corbo GM, Fantoni M.

The association between treatment with heparin and survival in patients with Covid-19

Ayerbe L, Risco C, Ayis S.

Patients with systemic lupus erythematosus using hydroxychloroquine or chloroquine develop severe COVID-19 at similar frequency as patients not on antimalarials: need to explore antithrombotic benefits for COVID-19 coagulopathy. Response to: 'Clinical course of COVID-19 in patients with systemic

Konig MF, Gianfrancesco M, Yazdany J, Robinson PC.

Global haemostatic tests in rapid diagnosis and management of COVID-19 associated coagulopathy in acute limb ischaemia

Fan BE, Chia YW, Sum CLL, Kuperan P, Chan SSW, Ling LM, Tan GWL, Goh SSN, Wong LH, Lim SP, Lim KGE, Tan HT, Ang MK, Lau SL, Ong KH, Ng J.

Acute pulmonary embolism in COVID-19 related hypercoagulability

Lorenzo C, Francesca B, Francesco P, Elena C, Luca S, Paolo S.

Venous thromboembolism and COVID-19

Bertoletti L, Couturaud F, Montani D, Parent F, Sanchez O; Circulation Pulmonaire et Interactions Coeur-Poumons group of the SPLF.

COVID-19-RELATED AORTIC THROMBOSIS: A REPORT OF FOUR CASES

Gomez-Arbelaez D, Ibarra-Sanchez G, Garcia-Gutierrez A, Comanges-Yeboles A, Ansuategui-Vicente M, Gonzalez-Fajardo JA.

Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: a multicenter observational study

Russo V, Di Maio M, Attena E, Silverio A, Scudiero F, Celentani D, Lodigiani C, Di Micco P.

COVID-19, hypercoagulation and what it could mean for patients with psychotic disorders

Mongan D, Cannon M, Cotter DR.

Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research

Bikdeli B, Madhavan MV, Gupta A, Jimenez D, Burton JR, Der Nigoghossian C, Chuich T, Nouri SN, Dreyfus I, Driggin E, Sethi S, Sehgal K, Chatterjee S, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Bertoletti L, Giri J, Cushman M, Quéré I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Tafur AJ, Francese DP, Batra J, Falanga A, Clerkin KJ, Uriel N, Kirtane A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Leon MB, Ston

COVID-19 and hypercoagulability in the outpatient setting

Emert R, Shah P, Zampella JG.

Abdominal Aortic Thrombosis Complicating COVID-19 Pneumonia

Roncati L, Manenti A, Manco G, Farinetti A.

Inferior vena cava filter in a patient with COVID-19 pneumonia to prevent a massive pulmonary embolism

Cena T, Bazzano S, Berni P, Vignazia GL, Grossi F, Stanca C, Cammarota G, Della Corte F, Vaschetto R.

Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID-19 patient with ST-elevation myocardial infarction

Seif S, Ayuna A, Kumar A, Macdonald J.